Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,21284,46,1.73 [0.33-9.17],0.5202285917624858
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,20668,42,0.65 [0.36-1.15],0.1389818113656382
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,24388,52,1.36 [0.89-2.07],0.1578607704512072
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,20596,45,1.59 [0.80-3.17],0.1894205071240742
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,24263,51,0.77 [0.49-1.20],0.2433193567396038
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,24388,52,0.87 [0.60-1.27],0.4728541496640182
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,21264,46,1.07 [0.88-1.29],0.5114600103215456
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,20596,45,0.95 [0.61-1.46],0.7989961627446461
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",23922,51,1.51 [1.18-1.92],0.0010008636191698
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",20857,43,1.00 [0.66-1.53],0.9859146220895152
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",21259,46,0.66 [0.47-0.94],0.0197320842301206
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,24289,50,2.11 [0.87-5.13],0.0986105659009979
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,21264,46,1.45 [0.49-4.28],0.502201338901352
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,24076,51,2.93 [2.20-3.91],2.6544140438630733e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,20778,43,2.82 [1.60-4.97],0.0003492336482517
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,21166,45,0.79 [0.62-1.01],0.0613950519795549
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,24516,50,0.80 [0.47-1.34],0.3949790899065444
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,20652,46,1.42 [0.82-2.45],0.2124493480080745
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,24590,53,2.89 [1.64-5.10],0.000257546779143
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,24696,54,1.39 [0.93-2.09],0.1096594067969344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,21142,45,1.40 [0.71-2.74],0.3331326373272651
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,20652,46,0.93 [0.63-1.37],0.7052173771823632
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,20596,45,1.73 [1.03-2.91],0.037634222158068
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",24076,51,1.19 [0.72-1.97],0.4992998120312946
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,20596,45,1.10 [0.69-1.74],0.6882659131003098
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,24062,52,1.49 [0.85-2.60],0.1666401410170816
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,24309,51,1.67 [0.62-4.47],0.3111900441898907
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,24516,50,1.88 [1.34-2.62],0.0002241113381514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,20596,45,2.04 [1.35-3.09],0.0007775854453375
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,20698,42,0.74 [0.47-1.17],0.1940694008147344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,24807,53,2.56 [1.55-4.23],0.0002321805496139
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,24328,51,4.12 [2.66-6.38],2.20764563923712e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,20652,46,1.63 [0.88-3.02],0.1227298841947361
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,24076,51,5.57 [2.69-11.56],3.900018905568063e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,24350,51,1.05 [0.52-2.12],0.8843107377924857
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,24807,53,0.89 [0.46-1.71],0.7201923038181154
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,24704,52,1.69 [0.74-3.81],0.2102352773561326
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,21166,45,2.99 [1.61-5.54],0.0005035268383514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,20652,46,1.78 [0.95-3.33],0.0725887892525578
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,24801,53,3.06 [1.12-8.36],0.0289365860360081
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,24388,52,1.21 [0.67-2.19],0.5340722543831604
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,24076,51,1.50 [0.95-2.37],0.0795393133632891
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,20652,46,1.10 [0.51-2.35],0.8140024652077235
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,24556,53,0.99 [0.58-1.68],0.9638179734904198
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,21251,46,4.83 [2.79-8.37],1.873884618197652e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,20668,42,1.70 [0.56-5.16],0.3489513166277012
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,21259,46,2.03 [1.17-3.54],0.0123140908272518
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,23922,51,0.91 [0.42-2.00],0.8191387574009874
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,20778,43,0.78 [0.51-1.18],0.2348592608816103
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,24309,51,2.75 [1.35-5.58],0.0052042831545986
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,20778,43,4.74 [2.79-8.05],8.218766291345678e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,21166,45,2.83 [1.88-4.26],6.026039437257681e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,24603,54,6.07 [3.10-11.87],1.3890877601043118e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,24663,52,5.44 [3.38-8.74],2.773687096784476e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,21259,46,1.13 [0.43-2.99],0.7995358672493562
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,24388,52,2.11 [1.71-2.59],2.3554375293711827e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,24516,50,3.08 [1.22-7.79],0.0174008138148697
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,20603,44,0.86 [0.54-1.35],0.5029285371079019
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,20778,43,1.05 [0.74-1.51],0.7745701746169964
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,24076,51,1.12 [0.84-1.49],0.4343973688689442
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,21284,46,1.09 [0.72-1.64],0.6793290300040244
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,24728,54,0.82 [0.33-2.03],0.6666664420324508
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,20596,45,1.36 [1.04-1.78],0.0271069276937247
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,20778,43,0.68 [0.46-1.01],0.0533653909942778
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AFM,Afamin,21284,46,1.18 [0.29-4.85],0.813515279675581
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,24273,51,1.38 [0.96-2.00],0.0825528534023317
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,20603,44,0.97 [0.71-1.34],0.8746552954449661
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,24436,53,1.27 [0.70-2.28],0.4307707460838289
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,23732,51,1.04 [0.81-1.33],0.781521929434957
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,23891,51,0.80 [0.52-1.25],0.3249654567601052
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,24603,54,2.66 [1.52-4.66],0.0006129480580841
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,24807,53,1.21 [0.76-1.92],0.4128727103959287
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,21264,46,0.65 [0.32-1.31],0.2316930633114346
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,24516,50,1.67 [1.27-2.18],0.0001962707400521
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,24516,50,0.87 [0.60-1.26],0.450062315608471
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,20668,42,1.19 [0.49-2.90],0.7036021903765335
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,20668,42,0.86 [0.30-2.43],0.7764944817388205
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,21142,45,0.83 [0.51-1.36],0.4646057708993787
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,21264,46,1.42 [0.50-4.03],0.5116576492415166
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,24460,52,1.16 [0.87-1.54],0.3084625362488598
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",20673,44,0.81 [0.53-1.23],0.3135987169567715
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,23922,51,1.13 [0.71-1.80],0.5970762498740195
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,20668,42,0.85 [0.48-1.53],0.5973952865559145
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",24344,52,0.96 [0.76-1.21],0.7174450953507944
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,24516,50,0.93 [0.63-1.39],0.726093140159336
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",21201,45,0.84 [0.64-1.09],0.1935419018200934
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,20778,43,0.84 [0.20-3.49],0.8107280147167648
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,23922,51,0.91 [0.65-1.26],0.5528162784262445
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,20673,44,1.31 [0.90-1.90],0.1580996329599977
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,24076,51,1.14 [0.76-1.72],0.5261374252114346
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,20652,46,1.62 [1.22-2.16],0.0008294063524715
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,23930,51,0.93 [0.64-1.35],0.7059817045711277
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,21225,45,0.75 [0.61-0.93],0.0093028259651387
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,23794,50,0.77 [0.50-1.20],0.2552364252605529
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,24801,53,27.79 [11.56-66.84],1.1162607154718469e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,24498,52,1.65 [1.14-2.39],0.0078918658206854
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",21142,45,1.13 [0.69-1.85],0.6159159123427482
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",24469,53,1.20 [0.88-1.64],0.2437706071257788
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",21225,45,1.08 [0.61-1.91],0.7979504458783625
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,20857,43,0.69 [0.32-1.50],0.3521598186094291
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,20652,46,1.05 [0.84-1.32],0.6615924710357088
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",24388,52,1.33 [1.07-1.66],0.0091038306278305
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,24062,52,1.41 [0.73-2.75],0.3104878328384144
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,24697,54,0.40 [0.12-1.37],0.1449501741874598
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,21251,46,1.75 [0.62-4.95],0.2910205789879157
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,23930,51,0.98 [0.66-1.44],0.90426956711104
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,20673,44,1.08 [0.63-1.85],0.7821712437895949
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,24388,52,4.82 [2.22-10.48],7.247814164797615e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,24062,52,0.76 [0.45-1.28],0.2987297947573438
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,20778,43,1.76 [0.91-3.39],0.094733330263721
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,21075,45,0.56 [0.26-1.21],0.1402452398502089
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,21201,45,1.08 [0.73-1.60],0.6937038012885146
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,19928,42,1.27 [0.76-2.12],0.3659925070599125
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,23592,49,1.38 [0.82-2.31],0.2273181046461566
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,22854,49,1.31 [0.79-2.17],0.3039824860270588
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,24403,51,0.56 [0.26-1.20],0.1345147485512961
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,24424,52,0.79 [0.60-1.05],0.1017961360577737
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,24728,54,3.24 [1.88-5.59],2.468541662786949e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,24155,49,6.24 [2.86-13.63],4.29929744277758e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,24522,54,3.26 [1.90-5.60],1.904968902468997e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,24492,51,1.67 [0.83-3.38],0.1504350824870288
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,24568,54,1.95 [1.16-3.30],0.0122584936256297
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,24728,54,2.95 [1.87-4.63],2.93554037065381e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,20596,45,1.16 [0.82-1.65],0.4059899737709473
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,20652,46,0.70 [0.49-1.01],0.0536794401361672
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,20503,43,0.98 [0.58-1.65],0.9382097588516586
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,23922,51,1.26 [0.87-1.83],0.2142506451173281
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,20668,42,1.31 [0.77-2.24],0.3225877264572363
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,24518,51,4.23 [2.30-7.81],3.856144135060074e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,20649,43,1.02 [0.55-1.92],0.9418870669864524
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,23930,51,1.13 [0.84-1.52],0.4270796514302987
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,24455,53,0.74 [0.53-1.03],0.0731949637142877
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,20372,42,0.89 [0.57-1.39],0.6039915322971736
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,24704,52,0.77 [0.54-1.09],0.1440709948383184
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,24392,50,0.74 [0.52-1.06],0.0999126498658584
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,23857,51,1.50 [0.70-3.21],0.2966951558336996
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],24062,52,0.89 [0.55-1.46],0.649669020850564
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,24563,51,4.65 [2.49-8.69],1.409227859067394e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,21142,45,0.72 [0.49-1.04],0.0821144825153433
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,20673,44,0.37 [0.18-0.79],0.0095603931833326
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,21166,45,0.79 [0.54-1.16],0.2296659804082851
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,21201,45,0.58 [0.30-1.13],0.108478885672045
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,24388,52,1.13 [0.69-1.86],0.6287026257504551
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,21106,45,0.73 [0.50-1.05],0.0881561115313495
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,24663,54,1.16 [0.79-1.72],0.4520274220325317
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,24516,50,2.02 [1.29-3.15],0.0021563072119653
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,21284,46,0.52 [0.16-1.70],0.2796962391448499
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,21264,46,1.24 [0.70-2.19],0.4570048071137236
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,21284,46,0.75 [0.32-1.77],0.5152116124245635
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,21264,46,0.56 [0.18-1.73],0.3096440315352993
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,20668,42,1.47 [0.71-3.05],0.3000464478106395
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,21242,46,0.69 [0.46-1.02],0.0622357461166606
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,20287,46,0.71 [0.49-1.03],0.0751028838897071
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,21284,46,0.93 [0.60-1.45],0.7475795183975906
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,21264,46,0.63 [0.42-0.95],0.0278566988852221
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,24498,52,0.97 [0.49-1.91],0.9322981560788968
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,21264,46,0.33 [0.18-0.59],0.0002108479859983
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,24534,51,0.61 [0.38-0.98],0.0425616191791971
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,24456,52,0.75 [0.52-1.09],0.1293151707441257
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,20778,43,0.74 [0.57-0.94],0.0152348903300109
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,24323,51,0.63 [0.39-1.03],0.0657709343787554
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,20857,43,0.66 [0.40-1.08],0.0981636055120485
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,24388,52,2.87 [2.01-4.09],5.464818353581599e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,21166,45,0.79 [0.62-1.01],0.0577487847028844
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,21225,45,0.71 [0.47-1.09],0.1174576988544052
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,24393,54,1.39 [0.89-2.17],0.1458229853479442
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",21142,45,1.04 [0.55-1.98],0.8947177957282622
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,23922,51,0.84 [0.49-1.44],0.5298573974817677
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,23922,51,1.06 [0.71-1.59],0.759557487520135
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,20857,43,0.36 [0.11-1.19],0.0935936108132541
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,20778,43,0.75 [0.52-1.07],0.1132741927492897
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,20503,43,0.79 [0.50-1.25],0.3129499366840487
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,21201,45,0.76 [0.56-1.04],0.0889062653869241
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,21225,45,0.90 [0.67-1.23],0.5179997003756376
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,24498,53,0.79 [0.63-1.00],0.047523973582373
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,20603,44,1.16 [0.82-1.65],0.3914925555743195
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,20603,44,1.27 [0.66-2.45],0.4731127228128994
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,23930,51,0.86 [0.45-1.65],0.6491405639450045
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,20596,45,0.64 [0.40-1.02],0.0617542590836887
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,20596,45,0.78 [0.38-1.59],0.4968925381425646
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,20603,44,1.17 [0.77-1.76],0.4603277496334438
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,24062,52,0.97 [0.50-1.90],0.9267285314165524
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,20596,45,1.34 [0.87-2.07],0.184787374514812
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,24498,52,1.60 [0.98-2.63],0.0613589839898189
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,24388,52,1.01 [0.65-1.56],0.9636222744131312
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,24563,51,0.94 [0.45-1.97],0.8732381427642272
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,20603,44,1.18 [0.81-1.73],0.3932253552912627
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,24062,52,0.99 [0.58-1.67],0.9628940439614484
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,21074,46,1.47 [0.92-2.33],0.1041460893765156
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,24350,51,1.22 [0.75-2.01],0.424466236617493
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,24350,51,2.08 [0.99-4.38],0.0538820603086238
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,21264,46,0.63 [0.21-1.87],0.4005688861276317
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,21259,46,3.02 [1.68-5.43],0.0002205177750131
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,21225,45,0.75 [0.49-1.15],0.1867311873341136
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,20668,42,0.87 [0.65-1.17],0.3701109521992493
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,20596,45,1.39 [0.99-1.95],0.0584365395088381
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,23930,51,0.91 [0.61-1.37],0.6660251365963312
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,20503,43,1.55 [0.76-3.16],0.2326218723063217
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,21166,45,0.73 [0.52-1.02],0.0672197889535064
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,23922,51,1.19 [0.80-1.77],0.3921651787939068
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,24556,53,0.86 [0.62-1.20],0.3777106369931419
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,20596,45,1.06 [0.62-1.83],0.8224081108917071
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,20596,45,1.34 [0.59-3.04],0.4829209688966275
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,20596,45,1.47 [0.88-2.46],0.1397267304882604
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,20503,43,1.85 [1.15-2.97],0.0112935885764703
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,20596,45,1.18 [0.81-1.73],0.3952456926589521
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",20596,45,1.45 [1.06-1.99],0.0203085219437672
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",24603,54,0.81 [0.66-1.00],0.0502082897184833
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",23930,51,1.18 [0.70-1.99],0.5239215919267717
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,23922,51,1.30 [0.79-2.14],0.3030606052443331
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,24388,52,0.60 [0.21-1.66],0.322778176297653
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,23883,51,0.80 [0.54-1.19],0.2734263574998332
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,20668,42,0.70 [0.45-1.07],0.0997079457503327
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,20596,45,1.02 [0.76-1.38],0.8807250652013348
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,21166,45,1.30 [0.69-2.44],0.418961816492914
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",21284,46,0.72 [0.29-1.75],0.4643715227230652
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,23930,51,0.85 [0.61-1.20],0.3609373554230659
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,20603,44,0.92 [0.69-1.24],0.6003195676634443
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,21225,45,0.67 [0.34-1.33],0.2505912720927613
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,21201,45,0.93 [0.59-1.48],0.7728406126339599
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,24498,53,0.80 [0.62-1.03],0.087898904471735
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,24563,51,4.00 [2.00-8.00],9.046081989857048e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,21225,45,0.61 [0.34-1.07],0.0845857843986301
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,23755,49,0.91 [0.64-1.29],0.5878741596995024
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,21284,46,1.23 [0.69-2.19],0.486376537723602
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,20596,45,1.86 [0.54-6.44],0.3254839542147465
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",20668,42,2.69 [1.25-5.78],0.0111600977702723
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",24603,54,3.31 [1.51-7.26],0.0028485875939584
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",24498,52,0.44 [0.16-1.20],0.1086509527255107
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,20652,46,1.48 [0.64-3.41],0.3615623855653747
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,24498,53,0.92 [0.65-1.28],0.6034112463912089
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,24309,51,0.75 [0.42-1.34],0.3294212620954947
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,20652,46,0.90 [0.50-1.63],0.725375122738865
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,24076,51,0.97 [0.49-1.92],0.919351185171763
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,23922,51,1.82 [1.35-2.47],9.864192464774182e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,23922,51,1.42 [0.65-3.11],0.3784844888837106
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,24498,53,0.82 [0.66-1.03],0.0820401507311801
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,21201,45,0.88 [0.57-1.37],0.5736554094820074
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,20673,44,0.81 [0.53-1.25],0.3449705434586571
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,23893,51,1.08 [0.83-1.42],0.5636553036404631
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,24498,52,8.82 [4.66-16.66],2.0937019776484783e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,24350,51,0.89 [0.44-1.82],0.7518788212486149
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",21259,46,0.70 [0.26-1.88],0.4779730486478841
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",20603,44,0.80 [0.42-1.52],0.489477333917852
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,20865,45,0.71 [0.42-1.20],0.2028881360716976
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,21166,45,1.11 [0.67-1.83],0.6832426346478343
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,21201,45,0.75 [0.57-0.99],0.0427311508622136
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",24498,53,1.02 [0.59-1.79],0.9311673555762664
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,20652,46,0.90 [0.54-1.50],0.6857843714414997
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,20503,43,0.77 [0.46-1.31],0.3361653278536667
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,21142,45,0.76 [0.36-1.58],0.4567054306591777
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,24498,53,0.77 [0.59-1.00],0.0517672581780994
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,21251,46,0.62 [0.46-0.83],0.001737611358049
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,20668,42,0.86 [0.52-1.43],0.5616780319849659
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,20503,43,1.19 [0.68-2.09],0.5437237025366546
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,21251,46,1.17 [0.85-1.61],0.3477501091406867
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,23889,51,1.28 [1.05-1.56],0.0142570507350441
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,20603,44,1.05 [0.70-1.56],0.8209484487175612
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,20596,45,1.39 [0.46-4.25],0.5600689474691491
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,24498,53,1.05 [0.74-1.50],0.7867138991074044
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,24498,52,0.78 [0.59-1.03],0.0810011973745088
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,23922,51,0.80 [0.53-1.19],0.2683803157568882
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,24801,53,0.93 [0.43-2.00],0.8540454995535598
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,20652,46,0.57 [0.24-1.35],0.2031598895361486
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,20603,44,0.86 [0.56-1.32],0.4856406130983942
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,21201,45,0.42 [0.18-0.94],0.0357752384275809
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,24498,52,1.29 [0.91-1.81],0.1479287674207327
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,20778,43,0.57 [0.22-1.50],0.2584670876023773
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,24309,51,1.80 [1.13-2.87],0.0134374580391361
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,24029,51,2.00 [1.13-3.55],0.017893795082723
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,20778,43,3.28 [1.63-6.61],0.0009077375256246
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,21259,46,0.62 [0.26-1.48],0.2831349239213926
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,20652,46,0.83 [0.42-1.62],0.5798591495821088
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,24076,51,2.84 [1.00-8.08],0.0508766723886635
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,20603,44,0.59 [0.32-1.09],0.0931486298579891
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,20668,42,0.74 [0.43-1.26],0.269769616267351
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,19933,40,0.91 [0.68-1.21],0.5018153272978823
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,24457,51,0.68 [0.47-1.00],0.0472534246419868
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,21226,46,1.25 [0.84-1.84],0.2684667265676446
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,20968,45,0.74 [0.58-0.95],0.0175313304341575
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,20857,43,0.46 [0.15-1.42],0.1740141385343592
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,20603,44,0.51 [0.19-1.43],0.202547276772554
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,20596,45,1.07 [0.61-1.87],0.8095122505946041
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,20596,45,0.61 [0.27-1.37],0.2271223396115144
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,23930,51,0.74 [0.42-1.29],0.2818418938584345
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,20603,44,1.32 [0.86-2.03],0.2012272528281811
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,21225,45,0.98 [0.47-2.02],0.95648079878021
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BSG,Basigin,24759,53,7.83 [2.86-21.46],6.246648938461792e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BSND,Barttin,20503,43,1.28 [0.60-2.73],0.520047837528771
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,24742,52,2.37 [1.05-5.39],0.0385890187157181
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,24742,52,2.70 [2.22-3.28],1.3836274248368606e-23
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,23922,51,0.94 [0.67-1.34],0.745454451213236
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,21284,46,0.64 [0.31-1.30],0.2166563614154533
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,20503,43,1.30 [1.08-1.57],0.0051841783611397
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,21104,45,0.74 [0.32-1.74],0.4903055101762538
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,24603,54,3.34 [1.48-7.53],0.0036432483811291
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,24498,53,2.14 [1.26-3.65],0.0050886701200807
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,20503,43,1.85 [1.28-2.69],0.0011105659187717
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,23930,51,1.32 [0.99-1.75],0.0569139031487942
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,20596,45,2.25 [1.25-4.02],0.0064664429297648
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,24677,53,5.17 [1.97-13.61],0.0008709175279978
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",21225,45,0.69 [0.38-1.25],0.2211272288669629
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,20652,46,1.49 [0.89-2.49],0.1301570771479658
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,24563,51,2.17 [1.44-3.27],0.0001972344601293
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,20778,43,6.57 [3.59-12.03],9.984557172390172e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,21225,45,2.07 [1.20-3.56],0.0086246381042641
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,20739,43,1.05 [0.57-1.92],0.878589017679498
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,21284,46,0.68 [0.30-1.52],0.3460715783605629
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,21248,46,0.40 [0.10-1.54],0.1816581037125995
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,21284,46,0.63 [0.31-1.28],0.2032229603657863
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C2,Complement C2,24534,51,1.88 [0.56-6.36],0.3087903822328103
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,23883,51,0.96 [0.53-1.73],0.8973408589831856
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,20673,44,1.02 [0.62-1.69],0.9374466999856924
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C3,Complement C3,20222,42,0.88 [0.42-1.83],0.7226752872218654
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,24556,53,0.61 [0.34-1.09],0.0973436103690849
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C5,Complement C5,21284,46,0.71 [0.26-1.92],0.5011394465745964
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,20797,45,7.76 [4.47-13.48],3.498136479508872e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,21201,45,0.67 [0.16-2.86],0.5910833871660639
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,21284,46,0.31 [0.13-0.72],0.0064286063893044
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,21264,46,1.21 [0.72-2.03],0.4680055417860942
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,21166,45,1.10 [0.78-1.56],0.571728748203885
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,23933,51,1.08 [0.72-1.63],0.7022533286325602
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,23922,51,1.45 [0.82-2.58],0.2010373108500323
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,24388,52,2.67 [1.66-4.32],5.732351080193839e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,24223,50,0.77 [0.62-0.96],0.0210642747180031
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,24728,54,0.91 [0.46-1.80],0.7795728733029603
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,24427,52,1.06 [0.74-1.50],0.7625193354863538
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,24759,53,0.97 [0.65-1.44],0.8881644227080062
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,24801,53,1.01 [0.37-2.77],0.984201329071259
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",24076,51,1.37 [1.08-1.73],0.0090107837334077
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,24421,52,0.67 [0.46-0.97],0.0344835941109834
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,20857,43,0.87 [0.36-2.13],0.7671478076076463
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,20652,46,1.49 [0.70-3.17],0.298513348811536
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,24728,54,2.74 [1.88-3.99],1.5226622175960366e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,20673,44,0.78 [0.47-1.28],0.3205790957174315
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,20603,44,1.55 [0.77-3.11],0.2185037612655212
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,20596,45,1.00 [0.62-1.61],0.998616664943332
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,20603,44,0.63 [0.35-1.13],0.1188970697213002
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,21225,45,0.70 [0.50-0.99],0.041191918405831
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,20731,42,0.75 [0.57-0.99],0.0437373135044051
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,20673,44,0.94 [0.47-1.91],0.8739186500391165
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,24388,52,0.83 [0.48-1.45],0.5189702776780338
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,23930,51,1.47 [0.79-2.75],0.2226207222398117
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,24303,51,1.61 [1.18-2.21],0.0030076607305474
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,21201,45,1.48 [0.83-2.66],0.1879506656393137
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,24657,53,0.91 [0.72-1.15],0.4151934219766146
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,20668,42,0.83 [0.56-1.24],0.371499910229817
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,20596,45,0.92 [0.41-2.10],0.8514387407086681
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,23922,51,0.90 [0.51-1.58],0.7063634662802272
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,20673,44,0.47 [0.24-0.93],0.0303406008776333
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,21225,45,0.77 [0.59-1.02],0.0685229216060281
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,24447,50,2.51 [0.74-8.60],0.1414899466855472
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,24356,53,1.46 [1.02-2.09],0.0380010172636866
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,21142,45,0.69 [0.29-1.65],0.3999173374759845
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,21201,45,1.10 [0.85-1.42],0.48305277972889
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,23930,51,1.18 [0.74-1.87],0.4972177857831212
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,20673,44,0.44 [0.20-0.95],0.0357660483240306
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,23930,51,1.24 [0.92-1.69],0.159675103668433
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,23930,51,0.76 [0.55-1.06],0.1041442157467052
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,24498,53,0.95 [0.67-1.36],0.7796709690187893
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,24801,53,0.80 [0.61-1.04],0.0980127818514878
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,20857,43,0.94 [0.78-1.14],0.550433781531422
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,21201,45,0.62 [0.44-0.87],0.0059299522131367
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,24665,54,1.18 [0.83-1.69],0.3536485402054919
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,20652,46,0.83 [0.52-1.33],0.4308888472484529
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,20596,45,0.54 [0.24-1.24],0.1462117366951171
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAT,Catalase,20938,45,1.43 [0.89-2.31],0.1414435417086887
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,24488,50,1.10 [0.77-1.57],0.5871609965058231
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,20603,44,0.97 [0.70-1.33],0.8466723474188409
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,24728,54,1.40 [0.73-2.71],0.3122303365379386
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,20668,42,1.68 [1.10-2.58],0.0173257820499847
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,20596,45,0.61 [0.23-1.60],0.311923714788299
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,24350,51,0.86 [0.61-1.22],0.4007901823721855
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,21201,45,1.06 [0.67-1.68],0.7990668123327581
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,21142,45,0.74 [0.41-1.35],0.3314470582795995
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,20673,44,0.79 [0.29-2.12],0.6380974591091698
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,21225,45,0.94 [0.64-1.38],0.7547133083963173
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,24516,50,2.59 [1.29-5.19],0.0075135509874687
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,20668,42,1.15 [0.72-1.82],0.5599120146180505
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,24807,53,1.43 [0.76-2.68],0.2643348398522804
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,24767,53,0.84 [0.59-1.19],0.3195820560003692
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,24403,51,1.43 [0.87-2.35],0.1607346594605423
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,24801,53,2.25 [1.42-3.56],0.0005179154377458
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,24801,53,1.01 [0.64-1.60],0.96853704654033
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,24439,54,0.85 [0.65-1.11],0.2344746284830893
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,24140,51,1.15 [0.86-1.55],0.3461449274879856
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,24742,52,1.18 [1.01-1.38],0.0340360828454165
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,24309,51,1.03 [0.65-1.63],0.9003665192175352
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,24807,53,1.44 [1.19-1.75],0.0002381757275143
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,24603,54,1.74 [1.20-2.52],0.0034567493707526
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,24214,54,1.63 [1.08-2.46],0.0193795166692242
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,24603,54,0.76 [0.43-1.34],0.3413942454037379
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,24568,54,1.14 [0.86-1.51],0.378607477327501
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,24807,53,1.83 [1.14-2.95],0.0129602665649336
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,24498,53,1.09 [0.85-1.39],0.5044503252526606
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,24516,50,0.85 [0.57-1.26],0.4205025796960612
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,24425,53,1.19 [0.81-1.75],0.383948796706308
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,24498,53,1.19 [0.91-1.55],0.2124985751680507
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,24515,54,0.99 [0.68-1.44],0.9717077410155364
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,24563,51,0.91 [0.72-1.15],0.4321440463075388
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,24498,53,1.27 [0.91-1.77],0.1658072573778439
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,24697,54,1.34 [0.90-1.99],0.1492113608434242
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,24354,52,0.97 [0.70-1.35],0.8762496498337634
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,24500,53,0.80 [0.53-1.22],0.2966835376042467
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,24759,52,3.01 [1.71-5.29],0.0001336596562748
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,24728,54,2.24 [1.37-3.67],0.0012904296204527
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,24498,52,0.82 [0.43-1.55],0.5422490415445288
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,20857,43,0.63 [0.34-1.16],0.1373280868480993
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,20652,46,0.91 [0.63-1.32],0.6261838696320818
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,24350,51,0.97 [0.57-1.63],0.905109459629963
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,23922,51,0.78 [0.43-1.42],0.4156669870463417
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,21166,45,1.02 [0.51-2.01],0.9654713259054918
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,24498,52,1.95 [0.94-4.04],0.0717705902920923
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,23955,51,1.77 [1.00-3.13],0.050298050702829
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,24807,53,1.41 [0.85-2.35],0.1880603259640551
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,24563,51,2.90 [1.85-4.57],4.024179673972672e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,24498,52,0.95 [0.36-2.50],0.9197998501882968
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,20673,44,0.56 [0.24-1.30],0.1761294950174762
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,24462,51,1.05 [0.86-1.29],0.6067449239173031
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,24556,53,1.52 [0.54-4.30],0.4266654782227677
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,20596,45,1.40 [0.84-2.33],0.1986403600836592
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,24498,53,2.55 [1.10-5.91],0.0295544503748962
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,24417,53,1.54 [0.78-3.01],0.2119147468894416
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,23972,51,1.80 [0.94-3.42],0.0746856287727942
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,24544,53,1.43 [0.78-2.64],0.2447095882673853
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,24807,53,2.44 [1.43-4.13],0.0009819310346926
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,20652,46,0.49 [0.25-0.97],0.0415174509981176
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,24807,53,2.18 [0.96-4.94],0.0629928068456879
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,21251,46,1.43 [0.72-2.85],0.3053995661709581
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,24556,53,2.60 [1.54-4.41],0.0003796393111692
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,24350,51,2.77 [1.63-4.73],0.0001755903921113
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,24483,54,2.53 [1.28-4.99],0.0075379571026787
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,23922,51,3.35 [2.08-5.39],6.264128491010553e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,24516,50,0.91 [0.62-1.35],0.6519191756521645
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,20778,43,2.91 [1.22-6.98],0.0163652554632558
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,24742,52,3.41 [1.88-6.18],5.164268013741801e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,24653,54,1.86 [1.05-3.28],0.0329567265959608
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,24728,54,1.69 [1.08-2.64],0.0224581661505996
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,24498,52,1.60 [0.83-3.11],0.1632724889252611
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,24388,52,1.38 [0.61-3.09],0.4363971207202731
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,24556,53,1.13 [0.82-1.55],0.4624678238768005
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,24647,52,1.52 [0.56-4.10],0.4083034032443091
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,20652,46,0.64 [0.34-1.20],0.1647739401651605
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,24388,52,1.16 [0.52-2.59],0.7137888200159632
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,20603,44,0.91 [0.38-2.19],0.8387405625972227
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,20857,43,0.73 [0.27-1.95],0.5237818525365354
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,20652,46,0.86 [0.58-1.26],0.4386770984656006
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,24454,53,1.57 [0.78-3.18],0.206862878453495
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,24480,54,1.47 [0.95-2.27],0.0805515421991966
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,24807,53,0.86 [0.64-1.16],0.3270008122293656
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,24318,51,1.87 [0.91-3.88],0.0906589906882691
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,24568,54,5.40 [2.64-11.06],4.058647738536207e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,24697,54,2.19 [1.13-4.26],0.0204482016783167
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,23628,49,2.25 [1.25-4.03],0.0065359488259825
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,24432,54,11.32 [3.27-39.15],0.000126388009614
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,23586,51,2.37 [0.92-6.12],0.0745273412262619
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,21173,45,1.90 [1.09-3.31],0.0236208834125376
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,24759,53,1.36 [0.87-2.14],0.1803503269801035
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,24309,51,0.64 [0.40-1.03],0.0668645886022808
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,24383,50,0.67 [0.51-0.88],0.0040640747880224
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,20618,46,0.60 [0.29-1.23],0.1645741558026858
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,24498,53,0.74 [0.42-1.31],0.3074994035440106
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,20778,43,2.51 [1.32-4.78],0.0049169864107638
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,24742,52,5.05 [2.86-8.94],2.6361756583444592e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,24807,53,2.84 [1.80-4.48],7.844803832167563e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,21259,46,5.06 [2.97-8.60],2.27927429680374e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,20857,43,1.80 [1.27-2.56],0.0009920931191663
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,24498,53,3.81 [2.02-7.19],3.508746983286281e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,24498,53,0.45 [0.21-0.97],0.0407126145973762
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,21166,45,4.17 [1.82-9.55],0.0007381276143141
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,24742,52,1.27 [0.78-2.07],0.3439145385904711
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,23532,50,3.54 [1.83-6.82],0.0001647222494247
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,24498,52,1.21 [0.34-4.32],0.7718236433696178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,24498,52,1.80 [0.67-4.85],0.2453101298463804
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,21225,46,0.96 [0.53-1.71],0.8789799084911855
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,21201,45,0.37 [0.09-1.49],0.1614159843639511
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,20503,43,1.32 [0.94-1.86],0.1107500434913178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,20503,43,0.52 [0.22-1.21],0.1277274116269316
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,21130,45,0.82 [0.53-1.24],0.3436261470167684
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,23922,51,0.95 [0.62-1.44],0.7924265938422994
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,24556,53,0.86 [0.64-1.14],0.297776786339573
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,21166,45,0.77 [0.58-1.04],0.0873003349407489
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,24350,51,2.34 [1.63-3.35],4.101894561985518e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,23644,48,2.05 [1.48-2.86],1.89969614271704e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,24695,52,1.76 [1.30-2.37],0.0002328413180092
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,24516,50,2.03 [1.50-2.76],5.130933453280627e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,24516,50,3.85 [1.99-7.45],6.268628965640146e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,20857,43,2.27 [1.23-4.20],0.0087770830967547
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,21201,45,0.77 [0.25-2.33],0.6409341793315132
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,24742,52,2.06 [1.09-3.92],0.0265851918557878
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,20603,44,0.88 [0.45-1.70],0.7013057440699504
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,24801,53,5.01 [2.72-9.23],2.282449067493424e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,24516,50,3.58 [2.29-5.59],2.1696596627275853e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,23930,51,1.10 [0.63-1.93],0.7436879425524632
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,24388,52,2.48 [1.78-3.44],6.099712847946988e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,24516,50,1.02 [0.53-1.95],0.9584974617294496
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,20503,43,0.95 [0.42-2.14],0.9097557022368226
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,21225,45,0.81 [0.48-1.35],0.4146264182916879
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,20603,44,1.11 [0.67-1.85],0.6773853291731705
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,24388,52,0.78 [0.62-0.98],0.0348085720174686
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,24388,52,0.82 [0.65-1.05],0.1176721124868682
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,24388,52,0.42 [0.19-0.94],0.0352272693149039
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,24527,54,0.84 [0.34-2.05],0.6980998772417252
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,24726,53,0.73 [0.42-1.29],0.2817218823688525
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,24518,53,17.40 [7.41-40.88],5.613567838691867e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,21166,45,0.76 [0.54-1.06],0.1048728041029622
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,20857,43,1.20 [0.86-1.66],0.2854598960516405
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,21166,45,0.51 [0.25-1.05],0.0679592356170968
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,20857,43,1.46 [0.90-2.37],0.1258821193167225
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,24498,53,1.17 [0.89-1.53],0.2581875769214116
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,23922,51,1.50 [1.02-2.21],0.03945799944987
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,23573,51,1.95 [1.40-2.72],7.816259913695835e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,21251,46,1.71 [1.17-2.50],0.0059764862747509
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,24076,51,1.09 [0.67-1.77],0.726299033518044
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,20652,46,1.09 [0.55-2.14],0.8049290135131575
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,24076,51,0.68 [0.34-1.37],0.2847545721454794
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,21251,46,0.70 [0.45-1.09],0.1119988750536026
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,24756,53,1.15 [0.77-1.72],0.506337787452529
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,20778,43,0.37 [0.13-1.06],0.0648004882893445
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,20652,46,1.77 [1.17-2.67],0.0066786549834424
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,20603,44,0.97 [0.59-1.60],0.9005042965046317
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,20857,43,1.32 [0.82-2.13],0.2522483534278369
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,20857,43,1.05 [0.71-1.55],0.8083993022240383
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,20596,45,1.58 [1.14-2.18],0.005731765871674
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,20503,43,1.09 [0.59-2.02],0.7850964100037321
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,24062,52,0.88 [0.56-1.38],0.5844926856030168
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,20668,42,0.63 [0.40-0.98],0.038739006727389
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,23922,51,0.89 [0.64-1.25],0.4997656375095531
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,20857,43,1.05 [0.62-1.77],0.8659692357312752
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,20503,43,0.41 [0.17-0.98],0.043851403237834
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,23883,51,0.85 [0.59-1.23],0.3923130595390283
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,23922,51,1.08 [0.73-1.58],0.7069821581512383
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,23930,51,0.88 [0.59-1.32],0.5348165639723057
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,24540,52,1.40 [1.10-1.79],0.0065156750126457
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,24388,52,1.51 [1.02-2.22],0.038634794719846
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,24388,52,0.96 [0.66-1.38],0.8160590528422673
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,23930,51,0.67 [0.45-1.00],0.048228318086746
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,21166,45,0.72 [0.50-1.04],0.0821133068416807
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,20892,44,0.61 [0.25-1.46],0.2634047562713766
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,23922,51,0.99 [0.57-1.71],0.9738520179013912
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,21284,46,0.40 [0.08-1.90],0.2490129113823643
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,20063,43,0.33 [0.10-1.13],0.0766440229476389
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,21131,45,0.70 [0.46-1.07],0.0960099160517502
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,21245,46,0.65 [0.46-0.93],0.0171808391981815
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,20995,45,0.45 [0.26-0.77],0.0035782287213447
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,21284,46,0.81 [0.41-1.59],0.533434927016468
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFP,Properdin,21284,46,0.63 [0.17-2.31],0.482186103453175
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,24498,52,1.03 [0.74-1.42],0.8784077591123359
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,21264,46,0.57 [0.28-1.16],0.1212860022723114
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,20673,44,1.58 [0.97-2.56],0.0639780365633281
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,24516,50,1.89 [1.08-3.31],0.0258785301786671
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,23922,51,1.02 [0.68-1.54],0.9228647931273836
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,20778,43,1.42 [0.79-2.57],0.2410412767513813
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",21201,45,1.70 [0.95-3.04],0.075194223627376
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,21142,45,2.08 [1.21-3.58],0.0079296982204103
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,24076,51,0.85 [0.40-1.82],0.6772576233439803
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,21251,46,1.14 [0.85-1.54],0.3701155615086136
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,24653,51,1.26 [0.68-2.33],0.4552792524988089
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,23911,51,1.90 [1.50-2.40],8.849226019564776e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,24593,52,1.21 [0.96-1.52],0.1012510430432851
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,24520,51,0.79 [0.34-1.80],0.568343087132553
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,20673,44,0.74 [0.45-1.22],0.2322294758169163
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,24350,51,0.76 [0.56-1.03],0.0782547895348223
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,21259,46,0.38 [0.23-0.63],0.0001728315827677
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,20603,44,1.02 [0.70-1.49],0.9215139492528284
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,24568,54,4.95 [2.45-9.98],7.947730954833459e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,24516,50,1.80 [1.19-2.72],0.0049979459301204
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,20673,44,0.99 [0.46-2.14],0.980016776861914
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,24556,53,0.96 [0.65-1.40],0.8259283092179123
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,21251,46,0.70 [0.44-1.12],0.1415143290807493
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,20857,43,1.01 [0.53-1.94],0.9768786173348089
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,21166,45,0.76 [0.57-1.01],0.0584109497249889
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,20673,44,1.34 [0.79-2.29],0.2806482548244192
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,24671,53,3.66 [2.36-5.67],6.184916817076923e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,21251,46,1.19 [0.75-1.89],0.4677127795592454
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",24385,54,2.10 [1.49-2.95],2.012725659138941e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,20503,43,0.69 [0.42-1.15],0.1525779905818467
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,24481,50,1.37 [0.99-1.88],0.0564247866909645
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,24350,51,2.07 [1.06-4.06],0.0334813815885556
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,24451,52,2.73 [1.66-4.51],8.362960664280626e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,20652,46,0.44 [0.10-1.98],0.2851651839019343
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,24498,52,3.04 [1.48-6.24],0.0025462661711918
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,24076,51,2.39 [1.18-4.83],0.0150728827222342
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,24742,52,0.70 [0.54-0.90],0.0064986511754215
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,20673,44,0.56 [0.25-1.26],0.1626131776492357
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,20798,44,0.72 [0.35-1.47],0.3608436741436679
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,24498,53,0.62 [0.33-1.17],0.1381285849769167
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,24498,53,1.55 [0.93-2.56],0.0900015503333764
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,24498,53,1.17 [0.80-1.71],0.4150429927692036
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,24498,53,0.63 [0.30-1.30],0.2091189635530238
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,21216,46,1.12 [0.63-1.98],0.697839398253101
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,24426,50,1.30 [0.57-2.99],0.5339479115252301
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,23922,51,1.86 [1.16-2.97],0.0099104098434709
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,24807,53,2.17 [1.25-3.74],0.0056196305300101
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,20673,44,1.93 [1.18-3.18],0.0092839466874828
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,20673,44,1.48 [0.78-2.79],0.2308153095392277
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,20503,43,1.23 [0.73-2.05],0.4371712221875781
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,24498,53,0.81 [0.66-0.99],0.0417408207981196
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,24728,54,3.04 [1.02-9.05],0.0462534869066072
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,20673,44,1.37 [0.64-2.93],0.4131888357497379
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",24303,51,0.89 [0.69-1.15],0.3806148211665148
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,24460,52,1.12 [0.79-1.57],0.5289789391524693
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,23883,51,0.93 [0.43-1.99],0.8516652159815254
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,23930,51,0.95 [0.57-1.57],0.8336040224842327
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,24807,53,2.89 [1.99-4.20],2.5418346070886054e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,21201,45,2.89 [1.69-4.95],0.0001119463778631
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,24076,51,0.84 [0.48-1.49],0.5568992289062441
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,21284,46,0.75 [0.45-1.25],0.2676070269237039
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,24477,50,2.02 [1.28-3.21],0.0027208199218445
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,21259,46,0.67 [0.49-0.93],0.0156193031928445
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,21142,45,0.70 [0.49-0.99],0.0438787006744726
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,24563,51,0.43 [0.28-0.66],0.0001040758501502
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,20603,44,1.24 [0.85-1.81],0.2688872530045991
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",20630,42,0.71 [0.49-1.04],0.0811971118103145
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,24076,51,0.50 [0.27-0.92],0.0252116593403498
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,24388,52,0.84 [0.61-1.16],0.2817777687558716
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNST,Consortin,24516,50,0.75 [0.60-0.94],0.0125293440994579
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,20603,44,1.16 [0.49-2.70],0.7388621624767342
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,24801,53,2.64 [1.07-6.52],0.0348702443103249
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,24728,54,1.97 [1.18-3.30],0.0096807645733997
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,24498,52,0.78 [0.37-1.65],0.5212036510184506
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,24498,52,3.35 [1.22-9.23],0.0191080211179012
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,24576,52,1.87 [0.97-3.59],0.0612713199051411
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,24498,53,2.99 [1.90-4.71],2.265517072020263e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,20673,44,0.95 [0.70-1.28],0.7328665953534055
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,21259,46,0.91 [0.50-1.68],0.7679798836896515
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,21251,46,1.17 [0.40-3.43],0.7683038007013105
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,24579,52,1.29 [0.45-3.73],0.6361283187571793
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,24801,53,7.15 [3.09-16.56],4.401512490071423e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,21166,45,1.12 [0.67-1.86],0.6630126697929527
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,20673,44,0.95 [0.66-1.36],0.7722134655581055
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,20668,42,0.96 [0.66-1.39],0.8329945912182224
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,21251,46,1.48 [0.46-4.77],0.5096129528736241
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,24516,50,4.83 [3.06-7.65],1.6003524807672348e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,20822,43,0.91 [0.54-1.54],0.7201794431652826
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,20778,43,2.97 [2.31-3.81],1.2724339323273605e-17
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,24801,53,3.04 [1.72-5.36],0.0001287166396438
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,24498,53,1.40 [0.86-2.26],0.1734157001530237
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,20857,43,0.82 [0.40-1.70],0.5974966923584508
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,24483,54,2.22 [0.90-5.47],0.0820343712083193
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,20668,42,0.73 [0.44-1.20],0.2111276093361432
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,21142,45,0.42 [0.18-0.99],0.0473492250098922
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,24224,51,1.65 [0.79-3.42],0.181375197886637
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,23802,51,0.78 [0.58-1.05],0.10206058778393
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',20596,45,0.89 [0.44-1.77],0.7315410811171554
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,23930,51,1.23 [0.79-1.93],0.3559907114665821
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",20668,42,2.42 [1.75-3.34],7.663225170756052e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,23995,49,0.87 [0.64-1.17],0.3495401713099898
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,20603,44,1.01 [0.47-2.18],0.9767271045769316
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",24388,52,1.11 [0.80-1.56],0.5255155176302875
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,21259,46,0.32 [0.12-0.82],0.0180051402273208
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,24801,53,1.22 [0.84-1.77],0.2857061351590793
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,24653,52,1.09 [0.76-1.56],0.6535151800179935
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,20363,41,1.57 [0.77-3.18],0.2138391156671377
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,24801,53,1.19 [0.81-1.74],0.376861694897467
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,21242,46,0.56 [0.29-1.09],0.0866827424936902
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,24550,54,0.81 [0.46-1.45],0.4795793254350962
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,20503,43,0.65 [0.23-1.86],0.4244269500700627
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,24636,50,2.61 [1.36-5.03],0.0040341309366769
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",20652,46,1.06 [0.38-2.94],0.9075159518809618
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,24742,52,0.88 [0.61-1.26],0.4824885185599084
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,21215,46,1.70 [0.78-3.70],0.1839887119937458
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,20596,45,1.48 [0.88-2.49],0.1397572130910275
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,24686,54,3.89 [2.14-7.05],8.155203229011782e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,24556,53,0.85 [0.60-1.20],0.3476172679368406
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,21259,46,4.52 [1.94-10.51],0.0004585392272504
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,21179,46,6.29 [3.30-11.98],2.349856329891344e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,24563,51,2.74 [1.65-4.53],8.892942708853357e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,23922,51,0.95 [0.70-1.27],0.7173106240459011
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,24303,51,0.70 [0.51-0.97],0.0311863338339065
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,20503,43,0.80 [0.44-1.45],0.4525725198948331
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,20503,43,0.66 [0.20-2.15],0.4861099498032887
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,24153,52,2.98 [1.82-4.90],1.5916801563844845e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,20778,43,1.82 [0.86-3.87],0.1202613221801429
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,24568,54,1.07 [0.69-1.69],0.7526827942178301
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,23881,51,0.91 [0.68-1.21],0.5123455015358538
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,24483,54,0.90 [0.38-2.09],0.7983527198688629
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,24076,51,1.07 [0.73-1.56],0.7418307731798169
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,24603,54,17.34 [9.42-31.91],4.931005745195812e-20
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,24350,51,1.40 [0.75-2.60],0.2867841634418562
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,24728,54,0.90 [0.60-1.36],0.6290654222226313
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,21058,46,0.78 [0.27-2.20],0.6345762862761382
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,24517,54,0.85 [0.68-1.06],0.1435202947412118
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,24603,54,0.73 [0.29-1.83],0.4990008053536875
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,23770,54,0.82 [0.57-1.18],0.2868499686914203
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,24801,53,0.31 [0.15-0.64],0.0015032639442634
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,24350,51,2.41 [1.52-3.82],0.0001952170883577
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,20673,44,0.65 [0.31-1.38],0.264051598794862
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,24076,51,1.16 [0.97-1.39],0.1083816707912337
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,21259,46,0.65 [0.42-1.02],0.0591113144812905
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,21201,45,0.64 [0.30-1.35],0.2409579979520727
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,21201,45,0.86 [0.64-1.15],0.3086998237615164
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,20603,44,0.87 [0.57-1.33],0.5188821689463023
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,20668,42,0.73 [0.53-1.01],0.0555071655577887
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,20596,45,0.98 [0.77-1.26],0.8955366154848181
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,24603,54,5.72 [2.71-12.07],4.561563414239834e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,21264,46,3.02 [2.12-4.29],7.78398707833893e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,20596,45,1.81 [1.05-3.14],0.0342631807542292
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,24350,51,1.22 [0.84-1.78],0.295302639690472
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,20652,46,1.59 [0.83-3.07],0.163355723450879
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,24062,52,0.92 [0.55-1.54],0.7396425657942187
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,20652,46,1.13 [0.48-2.65],0.7736324394523781
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,21264,46,1.13 [0.47-2.74],0.7838502855697052
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,20652,46,0.72 [0.44-1.19],0.2041470121988307
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,21225,45,1.00 [0.53-1.87],0.9917866652659492
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,21251,46,4.14 [1.88-9.13],0.0004331083151154
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,20603,44,1.17 [0.68-1.99],0.5717895107854691
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,20596,45,1.22 [0.96-1.55],0.1107418860135069
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,18411,38,0.99 [0.71-1.37],0.9338323844751508
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,24522,51,2.56 [1.16-5.65],0.0204886408583955
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,24063,50,1.32 [0.84-2.07],0.2248191018964335
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,23888,52,0.68 [0.41-1.14],0.1455474392680702
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,24515,54,1.03 [0.80-1.31],0.8405223021204155
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,24160,51,1.38 [0.79-2.41],0.251565259356276
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,20811,43,0.91 [0.50-1.67],0.7685193945919938
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,20968,44,0.91 [0.33-2.52],0.852585529638713
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,24076,51,0.81 [0.60-1.09],0.1661921656894874
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,21251,46,1.28 [0.47-3.50],0.6255805085637003
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,21251,46,1.24 [0.53-2.87],0.617975151287108
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,20603,44,1.30 [0.67-2.50],0.4389747357673379
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,24498,52,1.03 [0.66-1.59],0.910604811634148
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,24484,54,1.47 [1.03-2.10],0.0352168102324076
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,21201,45,1.03 [0.68-1.56],0.884875360439604
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,24490,52,2.04 [1.33-3.14],0.0011859969956272
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,24431,53,2.07 [1.30-3.29],0.0022452885194796
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,22839,48,2.37 [1.68-3.35],7.784700516391764e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,20778,43,0.99 [0.58-1.68],0.9562516395561372
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,24556,53,1.27 [0.70-2.31],0.4317036413326457
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,24009,51,1.27 [0.91-1.79],0.1613517522855713
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,24516,50,4.19 [1.70-10.34],0.0018992909332107
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,24807,53,2.46 [1.24-4.89],0.0101692426380334
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,19362,42,1.67 [0.49-5.63],0.4091699342124386
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,24654,54,0.95 [0.54-1.67],0.8491272555808189
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,24471,51,3.87 [1.93-7.76],0.000135101504245
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,20673,44,0.90 [0.41-1.97],0.7890342509360497
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,21049,45,0.76 [0.43-1.36],0.362802121984039
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,24350,51,2.08 [1.09-3.96],0.0262263849594888
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,24498,53,2.66 [1.88-3.74],2.5856112754989857e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,24433,54,1.10 [0.86-1.40],0.436845460656692
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,24603,54,1.42 [1.08-1.87],0.0117833525144046
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,24742,52,1.24 [0.95-1.64],0.1190025134054025
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,24062,52,1.85 [1.09-3.16],0.0235180242131053
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,24742,52,1.28 [0.93-1.78],0.1299127943120817
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,24062,52,1.14 [0.81-1.60],0.4549358629162009
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,24751,53,2.93 [1.11-7.72],0.0300028313502452
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,24807,53,1.29 [0.80-2.10],0.3008334682352436
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,24480,54,0.94 [0.73-1.20],0.6048724407212916
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,24431,50,0.85 [0.68-1.05],0.1216761990814804
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,24807,53,1.13 [0.83-1.53],0.443607722404175
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,24316,53,1.67 [1.39-2.02],7.006773135599686e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,24603,54,1.30 [0.93-1.80],0.122933720050443
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,20503,43,1.14 [0.82-1.59],0.4304269671149912
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,20911,44,1.06 [0.65-1.74],0.8214209330749392
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",20596,45,1.21 [0.94-1.56],0.1427392483030385
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,20503,43,1.06 [0.73-1.55],0.7680006120315012
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,21251,46,0.52 [0.16-1.72],0.2841329009778587
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,20778,43,0.73 [0.51-1.05],0.0855524289216414
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,24728,54,0.87 [0.70-1.07],0.1758751992712532
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,24603,54,1.31 [0.80-2.14],0.2835171056876705
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,20652,46,1.24 [0.85-1.81],0.2627485998102555
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,20652,46,1.01 [0.62-1.65],0.9650468184286186
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,24498,53,0.79 [0.67-0.94],0.007624520392778
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",24303,51,0.69 [0.50-0.96],0.0264105482396338
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,21230,46,0.90 [0.72-1.13],0.3799572445075415
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,24381,51,0.81 [0.59-1.12],0.2079700626611624
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,20652,46,0.48 [0.26-0.91],0.0242203332511364
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,24603,54,0.84 [0.65-1.09],0.1880205340837346
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",24556,53,1.99 [1.08-3.66],0.0280970260586573
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,20673,44,0.35 [0.07-1.70],0.1915363391206223
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,20503,43,1.32 [0.97-1.82],0.0814970479836579
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,20503,43,0.95 [0.37-2.46],0.9241544175531196
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCN,Decorin,24076,51,3.72 [1.29-10.72],0.0151847693421414
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,20778,43,0.73 [0.55-0.98],0.0378368350339341
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,24728,54,0.96 [0.66-1.38],0.8225808497917328
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,24388,52,1.16 [0.90-1.49],0.2398373126741182
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,23930,51,0.87 [0.60-1.27],0.4782886095756313
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,24516,50,3.18 [1.54-6.56],0.0017331280833664
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,20603,44,0.75 [0.46-1.22],0.2464158593745877
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,20503,43,1.04 [0.73-1.47],0.8303624934216832
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,24556,53,1.45 [0.97-2.16],0.0718647634468473
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,20596,45,0.80 [0.36-1.78],0.5841614377049342
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",24388,52,1.11 [0.66-1.88],0.6906049434638782
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,24488,50,2.13 [1.34-3.37],0.0013096733855519
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,21225,45,0.65 [0.42-1.01],0.0542149421504012
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,20778,43,1.05 [0.72-1.52],0.8162880906722021
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,24742,52,8.16 [4.67-14.25],1.5366731245225034e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,21251,46,1.79 [1.01-3.20],0.0471722095383289
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,21166,45,1.10 [0.65-1.84],0.725607628690836
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,20673,44,1.02 [0.48-2.16],0.9626500683361324
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,20652,46,0.73 [0.19-2.82],0.6463105938415717
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,20652,46,1.21 [0.82-1.77],0.3343668286910677
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,20673,44,1.12 [0.52-2.42],0.7696430446801795
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,23922,51,1.32 [0.97-1.80],0.0814496287377713
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",24498,53,0.90 [0.70-1.15],0.39715079095268
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,23983,51,1.23 [0.79-1.89],0.3578228230547595
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,20507,46,0.47 [0.20-1.13],0.092078916367059
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,20603,44,0.78 [0.43-1.40],0.3993897733136635
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,20603,44,0.76 [0.47-1.23],0.2676893571740206
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,20603,44,1.24 [0.86-1.77],0.2517948334993743
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,24129,51,1.01 [0.85-1.19],0.919891303612755
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,20596,45,0.76 [0.37-1.55],0.4470041035796943
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,20652,46,0.88 [0.53-1.48],0.6387385151571723
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,24807,53,0.92 [0.64-1.32],0.6590230095386178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,20603,44,1.26 [0.72-2.18],0.418163014528506
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,20652,46,0.66 [0.38-1.15],0.1424705813314934
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,24062,52,0.54 [0.26-1.11],0.0922918040599798
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,20596,45,0.88 [0.45-1.73],0.7087161578534975
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,21142,45,1.27 [0.71-2.30],0.422362118701315
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,21201,45,0.94 [0.51-1.76],0.8571166369053289
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",24426,50,0.78 [0.63-0.98],0.0315659697049617
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,20673,44,0.93 [0.46-1.89],0.8409657916502481
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,20778,43,2.48 [1.49-4.11],0.0004484733754138
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,24742,52,0.66 [0.45-0.98],0.0409965935117183
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,24801,53,7.60 [3.69-15.66],3.9282071444140614e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,24307,51,1.61 [0.99-2.61],0.0540183433602848
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,24388,52,1.32 [0.95-1.84],0.1025078572484318
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,21201,45,0.64 [0.41-0.99],0.0445813251931751
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,21225,45,1.28 [0.87-1.88],0.2170417981419112
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,24801,53,1.01 [0.66-1.54],0.971736641200152
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,24556,53,6.04 [3.06-11.89],2.0060395671286779e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,20668,42,1.00 [0.71-1.39],0.9783967141625864
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,20668,42,1.02 [0.56-1.86],0.9451562742706886
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,20668,42,2.42 [1.46-4.02],0.0005939167120989
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,20503,43,0.73 [0.35-1.54],0.412772947842413
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,24719,53,0.80 [0.60-1.07],0.1270883981016151
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,21201,45,0.96 [0.64-1.43],0.8489086056861072
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,24388,52,0.78 [0.59-1.03],0.0789117491839116
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,21166,45,0.66 [0.42-1.05],0.0808934178356049
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,20778,43,0.71 [0.41-1.25],0.2390784034592768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,20578,41,0.69 [0.48-0.98],0.0405430103271302
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,24076,51,0.93 [0.59-1.49],0.7760916331154328
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,21201,45,0.63 [0.28-1.41],0.2593344542663357
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,20668,42,0.83 [0.58-1.18],0.2974075149854652
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,21166,45,1.02 [0.71-1.47],0.9047107926020844
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,24447,54,1.61 [0.65-4.00],0.3039452086484837
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,20603,44,0.98 [0.69-1.39],0.9155608521995632
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,21166,45,0.80 [0.63-1.00],0.0549016846482785
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,21225,45,0.88 [0.51-1.52],0.6533202764395033
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,24350,51,0.77 [0.50-1.19],0.2385597822794771
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,21201,45,1.33 [0.82-2.16],0.251913232676285
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,24552,54,1.34 [0.85-2.11],0.2009495907408989
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,20673,44,1.19 [0.62-2.30],0.602131483220689
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,20603,44,0.83 [0.61-1.14],0.2525551663217897
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,21201,45,0.79 [0.65-0.95],0.014478845690789
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,24516,50,0.79 [0.64-0.97],0.0219096940230767
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,24303,51,1.15 [0.68-1.94],0.5951761758413834
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,24388,52,1.16 [0.50-2.66],0.7311117144559551
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,24498,53,9.93 [7.65-12.87],5.375595942852875e-67
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,23995,51,3.50 [1.77-6.95],0.000332945629874
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,24388,52,2.44 [1.24-4.84],0.0102715939227598
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,24311,49,1.16 [0.77-1.73],0.4824776374059606
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,24801,53,3.40 [1.26-9.18],0.0157083929839225
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,24663,54,1.33 [0.95-1.88],0.0992708639725003
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,24350,51,1.99 [1.14-3.46],0.0147456280889957
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,24388,52,0.69 [0.44-1.08],0.1063940904056262
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,24200,51,3.65 [2.00-6.65],2.333716703060201e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,21225,45,2.20 [1.06-4.58],0.0340462347538944
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,24498,52,2.49 [1.05-5.93],0.038975674030925
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,24656,53,0.77 [0.38-1.58],0.4745636345620408
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,24298,52,1.10 [0.68-1.78],0.6953867448064956
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,20778,43,0.72 [0.51-1.00],0.0511992172414906
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,21106,45,1.32 [0.74-2.38],0.347728868872783
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,20673,44,0.76 [0.44-1.31],0.321999952379815
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,24388,52,2.27 [0.94-5.51],0.06968029245892
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,21259,46,0.64 [0.43-0.97],0.035551301074142
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,24076,51,0.98 [0.68-1.39],0.8973968630291138
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,21142,45,0.46 [0.22-0.97],0.041152591147973
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,20673,44,1.31 [0.94-1.81],0.1115035209773306
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,23930,51,0.93 [0.69-1.27],0.6596563661429271
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",21166,45,0.80 [0.61-1.05],0.1005532019966197
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,21201,45,0.72 [0.38-1.37],0.3221629019446423
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,21142,45,0.76 [0.38-1.54],0.4468341769229903
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,20673,44,0.88 [0.61-1.28],0.5099933628781175
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,21142,45,0.67 [0.34-1.31],0.2408199567778101
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,24350,51,0.77 [0.59-1.00],0.0531174121067505
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,24696,54,3.29 [1.94-5.58],9.446210624766937e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,23930,51,1.93 [1.04-3.59],0.0362209592356062
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",21259,46,1.67 [1.28-2.18],0.0001379656089632
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",20668,42,1.04 [0.77-1.40],0.813862104586561
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,20596,45,1.07 [0.70-1.66],0.7454929910116557
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,20684,45,0.43 [0.24-0.79],0.0061337618286319
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,20603,44,0.43 [0.18-1.05],0.0637631762415655
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,24728,54,3.23 [1.90-5.51],1.5874557354331725e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,24498,53,0.71 [0.54-0.93],0.0136778339890204
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,21142,45,0.99 [0.57-1.70],0.9622433704274076
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,20596,45,1.32 [0.69-2.52],0.4048865902436511
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,21225,45,0.78 [0.48-1.26],0.3034205184747687
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,24076,51,2.29 [1.41-3.72],0.0007626931813152
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,20668,42,1.68 [0.62-4.58],0.309335560546945
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,20652,46,1.14 [0.64-2.04],0.6622255466654877
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,21259,46,0.77 [0.56-1.06],0.1049659754580018
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,21166,45,0.79 [0.26-2.44],0.6830091184404758
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,20857,43,0.60 [0.25-1.48],0.2682043773009125
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,24514,51,5.19 [2.78-9.67],2.214983580599234e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,21225,45,1.37 [0.67-2.81],0.39082501912645
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,24454,52,1.63 [0.69-3.86],0.270100576029798
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,24309,51,2.76 [1.32-5.76],0.0069486259218822
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,20673,44,1.36 [0.99-1.86],0.0603388492774252
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,24442,54,0.83 [0.67-1.04],0.1036507442504186
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,23922,51,1.46 [0.82-2.61],0.2022578904903166
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,21166,45,1.94 [0.98-3.83],0.0580696637025908
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,24801,53,0.47 [0.21-1.06],0.069378672020554
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,24498,53,1.33 [0.99-1.79],0.0572430148700175
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,21259,46,0.64 [0.43-0.96],0.0296304576443961
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,20668,42,0.77 [0.60-0.97],0.0266761962390623
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",21201,45,0.68 [0.36-1.28],0.2286825949265201
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",21104,45,0.79 [0.60-1.04],0.0875218732683694
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,20596,45,0.74 [0.45-1.22],0.2337638186032496
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,20668,42,1.03 [0.51-2.07],0.9374723020442044
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,24350,51,0.72 [0.48-1.09],0.1227582086639511
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,20652,46,0.76 [0.56-1.05],0.0952903698884642
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,24516,50,1.07 [0.73-1.56],0.7305100108161429
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,24807,53,0.96 [0.75-1.22],0.715966172664133
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,21225,45,0.70 [0.44-1.12],0.1386896909821958
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,20596,45,1.02 [0.54-1.92],0.9530008081048448
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,24062,52,0.57 [0.23-1.38],0.2103893130068173
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,21225,45,0.69 [0.50-0.96],0.0278172891020637
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,20603,44,0.96 [0.68-1.37],0.8261124526095603
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ELN,Elastin,21259,46,1.59 [0.71-3.58],0.2574370089528678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,24388,52,1.48 [1.12-1.94],0.0051366913378583
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,20596,45,1.25 [0.68-2.32],0.47345403774409
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,24062,52,1.27 [0.78-2.06],0.3362725946404665
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,19647,43,0.54 [0.30-0.97],0.0405260503180321
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,24801,53,49.83 [15.14-164.00],1.2702982263296283e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,24487,52,0.72 [0.53-0.97],0.0336709509252747
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,24742,52,0.72 [0.49-1.05],0.0898211132169835
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,20668,42,0.84 [0.50-1.40],0.4981814648002811
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,21142,45,0.71 [0.41-1.24],0.2310149819015275
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,20596,45,0.97 [0.34-2.76],0.9541469235055372
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,20596,45,1.30 [0.78-2.16],0.3122732640015913
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,24801,53,9.18 [5.49-15.36],3.23054089936356e-17
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,24603,54,0.91 [0.54-1.52],0.7190178560690308
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,20668,42,1.03 [0.45-2.35],0.9395635183622736
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,23785,50,2.11 [1.58-2.82],3.9891795561388186e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,21142,45,0.90 [0.52-1.54],0.6963154550389776
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,23922,51,3.58 [2.60-4.91],3.577044871017183e-15
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,24076,51,0.71 [0.23-2.22],0.5563260026490644
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,24076,51,3.47 [1.17-10.26],0.0246598416303184
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,20668,42,1.15 [0.74-1.80],0.538044586120989
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,20652,46,1.08 [0.44-2.62],0.8720417095829178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,20673,44,0.95 [0.59-1.52],0.8215103100539989
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,24487,54,1.25 [0.97-1.60],0.0843124767567589
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,21142,45,0.98 [0.54-1.78],0.9417535372331136
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,24552,54,1.73 [0.82-3.62],0.148107833076548
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,23930,51,1.11 [0.79-1.57],0.5466457686709059
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,23632,51,5.53 [3.43-8.92],2.23259018097411e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,20778,43,4.10 [1.54-10.90],0.0046388037465403
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,24801,53,4.67 [2.42-9.00],4.186873714789588e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,24303,51,2.77 [1.29-5.97],0.0092773995275851
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,24076,51,1.07 [0.73-1.58],0.7124781910184609
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,20857,43,0.62 [0.26-1.49],0.2844700390345913
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,24498,53,1.14 [0.86-1.52],0.3581478811352597
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,20668,42,1.06 [0.73-1.56],0.7494146982318974
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,24695,54,3.49 [2.10-5.79],1.3043025749695124e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,24556,53,5.98 [2.54-14.07],4.229638201939939e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,24388,54,0.65 [0.19-2.26],0.4935578271665705
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,24556,53,2.18 [0.82-5.83],0.1198392316935454
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,24388,52,0.81 [0.64-1.03],0.0797183116423356
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,20673,44,0.97 [0.65-1.44],0.8725571055444878
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,20503,43,0.91 [0.35-2.36],0.8405792813961233
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,24303,51,0.75 [0.53-1.04],0.085253132232817
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,20857,43,0.40 [0.15-1.06],0.0655742548381519
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,20652,46,0.59 [0.31-1.12],0.1066194560462005
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,21142,45,0.55 [0.26-1.18],0.1236210102907797
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,20778,43,0.77 [0.61-0.99],0.0383067355839758
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,24354,52,0.45 [0.17-1.18],0.1056128397891855
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,20596,45,0.99 [0.52-1.86],0.9632964005490232
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,24801,53,1.73 [0.85-3.49],0.1283728649650324
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,24483,54,5.92 [3.31-10.58],1.9604297443836446e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,20503,43,0.84 [0.45-1.57],0.5914995038323114
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,20652,46,0.67 [0.35-1.31],0.2449201341111158
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,21201,45,0.73 [0.51-1.06],0.0958393119881101
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,20503,43,1.33 [0.80-2.22],0.2682107211608713
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,20652,46,0.77 [0.56-1.06],0.1070616278743911
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,20857,43,0.50 [0.17-1.45],0.2006094185002946
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,20596,45,1.24 [0.86-1.79],0.2559504029474371
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,20596,45,1.33 [0.85-2.08],0.2185340778700641
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,24742,52,1.98 [0.77-5.09],0.1549220690166372
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,21264,46,0.64 [0.36-1.15],0.1384607997644058
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,20975,45,0.52 [0.31-0.86],0.0108326385027187
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,24498,52,0.90 [0.58-1.39],0.6264927083655248
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,21284,46,0.55 [0.30-1.01],0.0531561290090621
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,21173,45,0.74 [0.41-1.32],0.3075202855562925
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,21284,46,0.32 [0.11-0.88],0.0280668660979051
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,24568,54,0.80 [0.53-1.21],0.2923176723041151
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,24572,54,2.27 [0.99-5.21],0.0528482738367756
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,24523,51,0.52 [0.24-1.16],0.110651974516207
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,24534,51,0.62 [0.32-1.21],0.1622653713326309
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",24483,54,1.61 [1.30-1.99],1.576203153958132e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",24516,50,1.29 [0.96-1.73],0.0944849927305236
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",21259,46,1.16 [0.68-1.96],0.5824276079942113
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",24801,53,1.21 [0.76-1.94],0.4217331785473621
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,24673,50,0.74 [0.50-1.08],0.1160522100671949
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,24043,51,0.95 [0.60-1.50],0.8133028090348615
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,24498,53,0.94 [0.61-1.45],0.7828148519251745
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,24516,50,0.75 [0.54-1.04],0.0846262810312648
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,21166,45,0.56 [0.35-0.89],0.0140403859136792
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,21225,45,0.95 [0.78-1.15],0.5861921665209724
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,21142,45,0.66 [0.20-2.18],0.5006968793860717
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,20668,42,0.64 [0.39-1.05],0.0796074247453388
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,21259,46,0.89 [0.33-2.39],0.8200072600702621
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,24388,52,2.39 [1.19-4.79],0.0139377510522448
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,24488,50,1.31 [0.56-3.05],0.5366746762095729
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,21166,45,1.06 [0.76-1.48],0.730739581222464
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,24801,53,4.59 [2.00-10.52],0.0003223089560447
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,20673,44,0.60 [0.36-1.02],0.0572083336752845
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,24711,53,1.82 [1.24-2.66],0.0020392874410833
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,24807,53,1.50 [0.78-2.88],0.2231543130603494
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,21251,46,6.25 [3.10-12.59],2.9971504071123884e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,20673,44,1.22 [0.76-1.95],0.4069667726593344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",24516,50,1.15 [0.83-1.59],0.4031448113517406
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,21259,46,2.01 [1.43-2.82],5.064273570609105e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,24498,53,2.00 [1.22-3.27],0.0060515072693406
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,21225,45,1.59 [0.52-4.86],0.4159749811631565
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,24498,52,1.01 [0.60-1.70],0.9730444205210408
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,24368,50,1.96 [1.13-3.40],0.0169539458824906
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,23922,51,0.84 [0.55-1.31],0.447594935434735
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,24483,51,1.65 [0.97-2.80],0.0646863966236537
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,21230,46,0.99 [0.60-1.64],0.9762347580345412
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,24365,51,0.44 [0.33-0.59],4.108174876514736e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,24516,50,1.86 [1.07-3.24],0.0274677298362483
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,24700,53,2.07 [1.35-3.18],0.0008053198737354
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,24062,52,1.52 [0.97-2.38],0.0697457917482755
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,24498,52,1.81 [1.19-2.76],0.0056795817353268
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,24498,53,1.36 [0.95-1.96],0.09586303901613
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,23922,51,1.53 [1.11-2.10],0.009202049079131
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",20596,45,1.47 [1.12-1.94],0.0060238742156307
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",20596,45,0.93 [0.54-1.60],0.7928106766932126
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,23922,51,1.22 [0.94-1.60],0.1327694471046628
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,23922,51,1.44 [0.94-2.20],0.0934545814756613
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,24534,51,0.66 [0.36-1.20],0.1710458473222966
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,20787,44,0.60 [0.23-1.58],0.3012045834089308
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",21225,45,0.80 [0.56-1.14],0.2118847356915773
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,20652,46,1.30 [0.86-1.98],0.2198436707322667
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,20652,46,0.58 [0.28-1.19],0.1363729251364186
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,24603,54,1.10 [0.81-1.49],0.5437864913394097
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,24498,53,0.98 [0.69-1.40],0.918188280358618
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,20652,46,0.71 [0.32-1.60],0.412712000507571
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,24696,54,1.00 [0.82-1.21],0.9876084411048506
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,24689,53,1.14 [0.78-1.69],0.4972139229353437
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,20652,46,1.00 [0.40-2.50],0.994189031783872
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,24062,52,1.62 [0.83-3.18],0.1603560460026288
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,20652,46,0.78 [0.35-1.74],0.5376600051443422
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,20503,43,0.95 [0.65-1.40],0.8035539697548997
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,20460,43,0.52 [0.26-1.05],0.0680386639149797
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,24556,53,0.77 [0.38-1.59],0.4826997886637012
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,21251,46,0.51 [0.30-0.88],0.015613998694264
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,21201,45,1.06 [0.49-2.26],0.889145497872429
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,24556,53,8.36 [4.21-16.62],1.354224042017487e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,20778,43,0.47 [0.27-0.83],0.0091395477906669
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,21264,46,1.79 [1.16-2.75],0.0081469282414305
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,23930,51,0.87 [0.55-1.38],0.5606155845321632
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",20603,44,0.91 [0.61-1.35],0.6367092676523707
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,20596,45,0.89 [0.47-1.70],0.7318428481528505
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,23930,51,0.86 [0.62-1.21],0.3964039681798653
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,24464,54,0.92 [0.68-1.26],0.6111171436237625
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,21225,45,0.71 [0.53-0.94],0.017888026781469
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,24610,53,0.97 [0.78-1.20],0.7602493053052058
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,24350,51,1.15 [0.66-2.03],0.6212805607105072
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,24350,51,0.77 [0.59-0.99],0.0421159169269695
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,23883,51,1.21 [0.77-1.90],0.4032849632281229
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,21166,45,0.75 [0.46-1.22],0.2431662555078748
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,23922,51,0.88 [0.70-1.10],0.2619993603522321
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,24350,51,3.21 [1.67-6.15],0.0004399047742565
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,24347,52,2.25 [1.02-4.93],0.0437173918974391
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,23922,51,1.26 [0.63-2.54],0.5113084994001804
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,24807,53,2.00 [0.98-4.10],0.0566722596054069
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,24556,53,1.22 [0.60-2.50],0.5849310348175777
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,23930,51,1.09 [0.78-1.52],0.6204968447232999
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,23922,51,1.35 [0.68-2.68],0.3895558397815182
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,21284,46,0.33 [0.12-0.96],0.0409581254826195
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,21201,45,0.96 [0.53-1.75],0.8909600802369114
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,21142,45,0.70 [0.29-1.65],0.4105236728202575
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,20652,46,1.06 [0.83-1.36],0.6221970207512109
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,24435,51,1.98 [0.85-4.59],0.1108335995160801
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,24742,52,5.03 [2.47-10.28],9.060741697289913e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,24479,53,0.90 [0.77-1.05],0.1852339866010381
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,20460,43,1.24 [0.56-2.77],0.5985657286955096
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,23930,51,0.85 [0.42-1.71],0.6463317504722733
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,20652,46,0.58 [0.28-1.20],0.1427560549366083
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,24498,53,0.84 [0.63-1.12],0.2412072409533563
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,23922,51,0.83 [0.62-1.10],0.1844756900445815
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,20596,45,0.64 [0.40-1.02],0.0624605491247171
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,20673,44,1.45 [0.72-2.91],0.2977769294575813
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,24274,51,4.66 [1.64-13.23],0.0038018237963902
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,20668,42,0.92 [0.56-1.49],0.7227336704774523
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FST,Follistatin,24568,54,1.09 [0.68-1.75],0.7285568240508973
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,20668,42,7.72 [3.09-19.26],1.1973057732005942e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,24447,53,5.23 [2.99-9.13],6.404095602599747e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,21165,45,1.31 [0.98-1.76],0.0651649840620558
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,24632,53,1.46 [1.02-2.08],0.0370397826096906
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,20778,43,1.82 [1.25-2.64],0.0018189783304511
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FURIN,Furin,24556,53,0.99 [0.49-1.99],0.9777239916220904
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,23883,50,1.37 [0.77-2.43],0.2879350940363518
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",20822,43,1.59 [1.23-2.04],0.0003277871117779
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,24742,52,2.90 [1.79-4.70],1.5860487302523664e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",24350,51,0.94 [0.62-1.44],0.7868141126994881
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",24728,54,0.92 [0.67-1.28],0.6248600596529219
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,24062,52,0.74 [0.50-1.11],0.1429936335273615
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,24460,52,0.68 [0.53-0.89],0.0041988658345854
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,20673,44,0.76 [0.41-1.41],0.3867220601005816
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,20603,44,0.83 [0.39-1.77],0.6289591019920671
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,21142,45,0.88 [0.47-1.65],0.6938728303962265
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,20857,43,1.15 [0.79-1.68],0.4712336989086139
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,20603,44,1.07 [0.71-1.61],0.7495855861650942
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,20503,43,0.33 [0.11-1.01],0.0528528804075429
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,20652,46,1.07 [0.60-1.89],0.8190042989984121
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,20857,43,0.95 [0.50-1.81],0.8671278666101019
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,20668,42,0.63 [0.34-1.15],0.1300780052990665
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,20503,43,0.67 [0.37-1.25],0.208264130054547
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,24603,54,0.87 [0.60-1.27],0.4790071582511561
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,24388,52,3.97 [1.96-8.06],0.0001358058315019
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,24728,54,3.75 [1.53-9.20],0.0038213813654261
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,24062,52,2.14 [1.26-3.64],0.0048794454892314
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,21259,46,2.49 [1.05-5.88],0.0380975751177987
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,24388,52,0.85 [0.26-2.74],0.7798039834193443
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,20596,45,1.64 [1.02-2.63],0.0403943898920528
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,20333,41,0.60 [0.27-1.34],0.2157725364212088
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,21225,45,1.20 [0.42-3.37],0.7353171604618718
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,20857,43,1.21 [0.76-1.92],0.4247848245290944
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,24623,52,15.28 [7.13-32.72],2.2868359508512808e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,20596,45,0.52 [0.27-0.99],0.0452230098438435
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,21201,45,0.91 [0.71-1.17],0.4516415627724466
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,20503,43,0.56 [0.18-1.72],0.3091544671986271
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",20668,42,0.89 [0.61-1.31],0.562064127497721
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,20673,44,0.67 [0.39-1.16],0.1547892355796475
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,21162,45,1.27 [0.84-1.93],0.2620687055330235
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,24062,52,1.09 [0.73-1.64],0.668110125912116
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,23930,51,0.89 [0.53-1.51],0.6772348764412115
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,20596,45,0.93 [0.47-1.82],0.8319651728635449
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,21284,46,0.70 [0.24-2.11],0.5316590380815283
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,21201,45,0.78 [0.60-1.00],0.0534619674478922
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,23922,51,1.06 [0.87-1.29],0.5675600023637628
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,20266,41,1.48 [0.93-2.36],0.1009751745607788
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,20596,45,0.81 [0.40-1.64],0.5598229635975286
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",24388,52,2.94 [1.56-5.54],0.0008323777842585
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,24801,53,2.57 [2.04-3.22],5.86335658239912e-16
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,24516,50,1.05 [0.52-2.11],0.8900502872748548
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,23930,51,2.73 [1.69-4.41],4.267178137356998e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,21259,46,0.77 [0.43-1.36],0.3619345710680032
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,23888,51,1.51 [0.89-2.57],0.1273855728045068
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,23922,51,1.20 [0.83-1.74],0.3351293384367508
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,23922,51,1.02 [0.85-1.23],0.8027290093592889
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,24696,54,3.05 [1.38-6.75],0.0059257927987736
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,24388,52,1.78 [0.55-5.75],0.3349317961663449
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,24269,51,1.77 [0.75-4.19],0.1910243784592295
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,20595,45,0.96 [0.61-1.52],0.8622296585417598
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,23930,51,0.88 [0.60-1.30],0.5240850510135693
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,21259,46,0.59 [0.39-0.90],0.0141433971388046
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,21222,46,0.56 [0.30-1.03],0.0628503231028246
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,24045,50,0.92 [0.44-1.93],0.8332138220808909
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,24454,52,2.69 [1.97-3.69],6.681108187500683e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,24350,51,4.46 [2.55-7.79],1.6323349272443269e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,24488,50,1.14 [1.00-1.30],0.0522768851114192
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,23922,51,0.98 [0.84-1.14],0.778860040935124
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,20778,43,0.94 [0.34-2.61],0.9070760345634252
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,23930,51,1.25 [0.89-1.76],0.196448394768376
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,24516,50,0.66 [0.49-0.88],0.0056549800523256
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,21225,45,1.63 [1.00-2.66],0.049044478645127
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,21225,45,0.84 [0.57-1.24],0.3765181043907313
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,20778,43,1.06 [0.44-2.54],0.9003080925015573
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,20503,43,1.14 [0.67-1.96],0.6252608793647536
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,20668,42,1.30 [0.71-2.40],0.3981431181415111
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,21201,45,2.88 [1.33-6.26],0.0073151714034289
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,21166,45,0.72 [0.55-0.94],0.0150626487709005
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,20652,46,1.00 [0.55-1.82],0.990254171873961
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,20652,46,0.74 [0.55-0.99],0.0453505249094193
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,20503,43,1.10 [0.71-1.70],0.6641549879025732
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,23466,51,0.70 [0.28-1.72],0.4364488632080798
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,20731,42,1.74 [0.85-3.55],0.129783541019101
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,24350,51,1.49 [0.86-2.59],0.1565736806759719
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,20652,46,0.71 [0.27-1.89],0.495412827627514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,24076,51,0.91 [0.59-1.40],0.6736462584067902
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,24429,54,1.08 [0.55-2.10],0.8279738111361242
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,20603,44,1.20 [0.62-2.34],0.5932984956096021
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,24363,49,1.05 [0.68-1.61],0.839338205144195
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",20778,43,0.74 [0.53-1.04],0.0801956956564575
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,23930,51,1.32 [0.90-1.94],0.1516136670790972
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,21142,45,0.75 [0.42-1.34],0.3313089130669345
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,20747,44,1.47 [0.86-2.50],0.1563576144942259
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,21259,46,0.61 [0.42-0.90],0.0132571900537308
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,24807,53,0.87 [0.54-1.41],0.5806708040083759
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,20778,43,0.77 [0.49-1.19],0.239171287127672
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,21225,45,0.98 [0.71-1.37],0.9254521957910384
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,23922,51,1.02 [0.70-1.48],0.93788756237112
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,20673,44,1.14 [0.71-1.83],0.588394692288209
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,24498,52,0.89 [0.57-1.40],0.6166806421101778
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,20668,42,0.84 [0.32-2.19],0.7196528726693997
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,20778,43,0.41 [0.18-0.94],0.0356411716459077
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,21225,45,0.67 [0.45-1.00],0.0520605986627268
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,24742,52,4.00 [1.66-9.67],0.0020463602610464
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,24498,53,0.80 [0.63-1.00],0.0529191417445125
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,21166,45,0.50 [0.26-0.95],0.0336831309959857
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",21251,46,2.04 [1.36-3.06],0.0005247332578672
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,24373,51,0.32 [0.15-0.70],0.0040990141143871
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,20596,45,0.61 [0.40-0.94],0.0245959437979784
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,23762,51,1.36 [1.07-1.73],0.0123491856530096
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,20778,43,0.48 [0.23-1.00],0.0485451276465004
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,24460,52,0.70 [0.54-0.92],0.010723830762266
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,24388,52,1.01 [0.84-1.21],0.9189489643147046
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,24728,54,1.59 [0.69-3.62],0.2744866432391568
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,24350,51,0.39 [0.25-0.61],2.512107694703451e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,21142,45,1.59 [1.01-2.50],0.0450063482893812
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,21166,45,1.12 [0.66-1.91],0.6742649716858813
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,21264,46,0.53 [0.28-1.01],0.0520434115464205
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,21166,45,1.25 [0.81-1.93],0.3071799569273978
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,23930,51,1.61 [0.92-2.81],0.0932838369167493
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,23858,48,3.03 [1.29-7.10],0.0106652429313043
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,20603,44,0.77 [0.42-1.41],0.3976722603022109
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,21225,45,0.62 [0.24-1.59],0.3214322875494202
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,21166,45,1.47 [0.96-2.25],0.0757971350773375
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,24076,51,1.15 [0.78-1.69],0.478251829536517
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,21142,45,1.71 [1.37-2.12],1.4706663845347196e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,24516,50,0.81 [0.67-0.97],0.0246989853118302
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,21259,46,0.71 [0.46-1.10],0.1304868959575796
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",21225,45,0.38 [0.15-0.97],0.0427266687967995
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",20603,44,0.90 [0.51-1.61],0.723559582849743
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,24076,51,0.95 [0.58-1.56],0.8369205449952597
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,24378,51,4.15 [1.83-9.40],0.0006655700123823
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,20668,42,1.02 [0.58-1.79],0.9429812571909466
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",24388,52,1.78 [1.33-2.38],9.81672169642962e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,20386,43,0.65 [0.43-0.97],0.0361154463098832
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,23922,51,1.03 [0.79-1.36],0.8077167626051057
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,21178,46,0.56 [0.25-1.24],0.1532397163875686
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",21143,46,1.49 [0.43-5.22],0.5321576770861887
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,24481,50,1.44 [1.12-1.85],0.0048969669057528
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,23922,51,1.41 [1.08-1.83],0.0117220747979734
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,20596,45,0.94 [0.62-1.43],0.7729866211346478
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,23777,51,0.79 [0.53-1.17],0.2406624593878683
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,21201,45,1.03 [0.92-1.16],0.583136047022347
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,20857,43,1.38 [1.08-1.78],0.0110074474532834
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,20673,44,0.67 [0.46-0.98],0.036914967457624
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,24379,52,1.01 [0.47-2.16],0.988652896306962
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,20857,43,1.08 [0.79-1.49],0.6244669039073989
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,20596,45,0.87 [0.39-1.93],0.7361371237340493
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,24590,53,1.51 [1.05-2.15],0.0247975705469584
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",24076,51,0.82 [0.62-1.08],0.1586306339132706
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,24807,53,1.15 [0.58-2.29],0.6833721897055443
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,24498,53,1.10 [0.77-1.57],0.59065888617288
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,24076,51,1.04 [0.76-1.44],0.7898256977801343
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,20503,43,1.10 [0.64-1.89],0.725365515352794
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",20596,45,0.81 [0.46-1.43],0.4617535805166837
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",24665,54,1.26 [0.92-1.74],0.1555385102793361
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,24728,54,1.30 [1.10-1.54],0.0025849702549358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",24498,52,0.76 [0.56-1.04],0.0869566452625832
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,24697,54,2.58 [1.98-3.36],2.258033894240577e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,24498,52,3.54 [2.08-6.02],3.2010909091885018e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,24665,54,0.68 [0.49-0.95],0.0220630577591246
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,24728,54,1.61 [1.14-2.26],0.0062852685897875
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,21259,46,1.19 [0.93-1.53],0.1655612224530676
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,20596,45,1.07 [0.66-1.73],0.7792916776730194
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,24807,53,0.82 [0.53-1.27],0.373291257372112
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,20652,46,0.84 [0.48-1.47],0.5428096642281077
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,20603,44,1.06 [0.69-1.63],0.8003218047067923
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,21166,45,0.91 [0.47-1.76],0.7833015182581469
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,24698,54,1.05 [0.82-1.36],0.6800590726649599
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,21201,45,0.62 [0.38-1.01],0.0553668759580626
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,24076,51,1.19 [0.83-1.72],0.3439893834123041
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,20778,43,11.28 [4.81-26.44],2.45910232528578e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,21201,45,2.70 [1.44-5.08],0.0020249065654177
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,21259,46,3.23 [1.11-9.41],0.0315859412831561
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,24498,53,0.86 [0.63-1.16],0.3230251254451665
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,24807,53,4.39 [3.04-6.34],3.1297400572929578e-15
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,21067,46,0.64 [0.37-1.09],0.1015616375614975
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,23922,51,0.93 [0.68-1.29],0.6822980227016443
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,21201,45,0.79 [0.54-1.15],0.2206386978205149
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,20652,46,1.12 [0.78-1.61],0.5526448005093796
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,20596,45,1.36 [0.75-2.48],0.3159914512867593
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,21167,45,1.46 [1.05-2.04],0.0238467445723548
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,21225,45,0.80 [0.40-1.60],0.5210612884149973
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,24076,51,1.02 [0.42-2.50],0.9643352132249016
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",21225,45,1.98 [0.82-4.81],0.1309976993194044
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",24415,53,2.30 [1.28-4.12],0.0051324922420336
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",24498,53,2.11 [0.98-4.53],0.05577333674049
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,24728,54,1.67 [0.96-2.94],0.0717316487278783
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,20736,43,0.87 [0.53-1.44],0.5926952831841812
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",20668,42,0.94 [0.52-1.69],0.8278713701435734
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",20596,45,0.99 [0.52-1.89],0.9751464970651912
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,20467,43,0.66 [0.31-1.39],0.2712349812715195
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,24241,50,1.99 [1.24-3.18],0.0042920507016129
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,23930,51,1.95 [1.45-2.61],8.250036548549357e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,20673,44,1.28 [0.98-1.67],0.0758320696059911
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,24228,51,1.85 [1.16-2.95],0.0096579949016534
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,23990,51,0.71 [0.50-0.99],0.0458881423346877
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,21225,45,0.89 [0.49-1.63],0.7078647874396102
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,24807,53,0.78 [0.57-1.06],0.1072034114862621
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,23922,51,0.43 [0.22-0.84],0.0139803492892401
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,20971,45,0.74 [0.55-0.98],0.0340466019288819
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,20828,43,1.17 [0.93-1.46],0.1742420759005578
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,20668,42,1.61 [0.83-3.11],0.1568725794489827
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,21173,45,0.52 [0.22-1.25],0.1449630141025271
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,20668,42,0.80 [0.57-1.12],0.1883969668204071
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,24388,52,0.54 [0.28-1.02],0.0578895341282073
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,24728,54,1.90 [1.14-3.16],0.0142768189786156
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,20652,46,0.69 [0.29-1.65],0.4038292424598633
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,20668,42,1.02 [0.75-1.39],0.9031875714067348
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,24498,53,0.75 [0.42-1.35],0.3342614096050912
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,21201,45,0.93 [0.59-1.45],0.7383209474217238
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,20596,45,0.82 [0.43-1.56],0.5358175433852139
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,20668,42,0.60 [0.31-1.15],0.124180846950613
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,23826,51,0.96 [0.65-1.42],0.8290216560644805
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,24552,54,1.02 [0.73-1.41],0.9197311787063716
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,21142,45,1.12 [0.51-2.45],0.7702307096125711
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,24099,50,0.70 [0.51-0.97],0.0320352828918939
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,24728,54,1.17 [0.63-2.18],0.6099137208185612
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,24287,50,3.02 [1.61-5.69],0.0006032015955588
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,20603,44,1.16 [0.84-1.60],0.3598165027418114
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,20603,44,1.12 [0.59-2.15],0.723887956642862
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",24556,53,1.25 [0.86-1.83],0.2426877165290899
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,24326,51,3.35 [1.41-7.98],0.0062479623665812
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,24801,53,1.32 [0.44-3.95],0.6226369224535007
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,24062,52,0.80 [0.58-1.10],0.1660308333309974
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,24373,51,6.31 [3.75-10.62],4.06816869379752e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,24801,53,4.25 [1.96-9.20],0.0002448099007026
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,24801,53,5.84 [2.65-12.85],1.1792994107784008e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,24498,53,1.61 [1.01-2.57],0.0443681747334186
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,24516,50,2.19 [1.27-3.78],0.0049682918238178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,24388,52,2.16 [0.59-7.83],0.2422878138691306
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,20857,43,1.19 [0.69-2.02],0.5335308835748598
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,23930,51,0.90 [0.52-1.55],0.7001950190115047
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",20668,42,1.73 [1.23-2.42],0.0014232670488011
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,24807,53,0.58 [0.13-2.49],0.4608833585236112
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,24728,54,1.37 [0.81-2.32],0.2383963391852295
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,20686,43,2.36 [1.32-4.25],0.0040069968332326
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,20857,43,0.83 [0.45-1.53],0.5519078955279534
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,20857,43,0.72 [0.31-1.64],0.4289333185317567
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,21166,45,0.53 [0.18-1.54],0.2431269958173328
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,24062,52,1.26 [1.03-1.56],0.0283684720609545
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,24603,54,3.92 [2.15-7.14],7.842953773506571e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,24350,51,1.48 [0.96-2.29],0.0749848766101079
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,23930,51,2.46 [1.81-3.34],7.056487287204551e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,20603,44,0.97 [0.61-1.55],0.8995790944069926
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,24498,53,1.31 [0.73-2.35],0.3717451510257413
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,20596,45,0.69 [0.27-1.79],0.450676445549568
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,20673,44,0.43 [0.19-0.94],0.0340449963784401
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,21225,45,0.84 [0.53-1.34],0.4705783619611702
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,20603,44,1.11 [0.66-1.87],0.7006454839765928
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,21251,46,0.52 [0.20-1.33],0.1700226116213633
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,24388,52,1.78 [0.95-3.31],0.0703080167124968
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,20596,45,1.04 [0.57-1.91],0.8910912950486204
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,24498,52,2.69 [1.01-7.16],0.0471845446463641
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,24759,53,1.25 [1.03-1.52],0.0252966770972327
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,24753,52,1.21 [0.83-1.77],0.3209356055224256
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,24563,51,0.49 [0.31-0.77],0.0019205439212016
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,24178,52,1.43 [0.82-2.51],0.2114171899356727
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,24374,51,1.06 [0.44-2.56],0.8958219609073166
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,24801,53,3.60 [2.77-4.68],1.3699548331943e-21
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,24516,50,4.42 [2.66-7.34],9.36672317489145e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,20652,46,0.91 [0.59-1.40],0.6806161465342562
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,20596,45,1.03 [0.63-1.70],0.90492992039385
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,21253,46,1.59 [0.81-3.12],0.1748822251377232
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,20503,43,0.91 [0.64-1.31],0.6202064118508556
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,20668,42,1.49 [0.86-2.59],0.1566264355345619
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,24388,52,3.38 [2.50-4.58],2.8475910430739744e-15
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,24516,50,1.40 [0.64-3.10],0.4002917260169907
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,21259,46,1.48 [1.10-1.99],0.0087881011061498
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,24498,53,0.83 [0.63-1.08],0.1656438492938098
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,23922,51,0.97 [0.73-1.30],0.8421297453925236
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,24062,52,1.20 [0.93-1.56],0.1586035220461346
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,24062,52,1.21 [0.87-1.69],0.2515294691737788
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,24603,54,3.11 [2.04-4.74],1.3093319860282988e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,24062,52,0.87 [0.56-1.34],0.5254980096406373
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,24388,52,1.50 [1.11-2.03],0.0079694907577365
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,24807,53,2.04 [1.32-3.15],0.0013099172466105
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,24062,52,2.07 [1.15-3.75],0.0158014840748757
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,20652,46,1.10 [0.57-2.11],0.7692965608205408
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,24062,52,1.21 [0.85-1.74],0.2937354061117309
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,24166,52,3.83 [1.33-11.07],0.0129901593019724
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,20603,44,1.07 [0.40-2.90],0.8877515965526183
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,24498,53,2.56 [1.48-4.43],0.000742244207005
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,24062,52,1.42 [0.70-2.87],0.3353323516950054
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,24807,53,1.01 [0.58-1.76],0.9785912115138178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,24019,52,1.06 [0.61-1.84],0.8393274905770564
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,24062,52,1.57 [1.20-2.06],0.0011778954984905
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,24062,52,1.35 [0.75-2.43],0.3175358982590237
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,24062,52,1.13 [0.86-1.49],0.3698618731204025
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,24498,52,1.10 [0.63-1.91],0.7295672291873578
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,24180,51,1.00 [0.63-1.57],0.992341560031115
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,24392,54,1.61 [1.01-2.57],0.0435664635290168
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,24563,51,4.52 [2.80-7.28],5.74528456042148e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,24807,53,4.77 [2.55-8.93],1.0297923025180787e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,24195,51,0.93 [0.79-1.08],0.3391298374728809
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,23908,48,1.52 [1.14-2.04],0.0047472794980038
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,24062,52,0.92 [0.58-1.47],0.7302733145671555
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,23945,52,1.22 [0.83-1.80],0.3066241189743415
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,24454,52,4.12 [1.92-8.83],0.0002752701303948
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,24443,54,4.03 [1.19-13.65],0.0253684970045823
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,24498,52,0.47 [0.26-0.88],0.018375181752586
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,24711,53,3.05 [1.85-5.03],1.1796255581508733e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,24062,52,0.59 [0.32-1.09],0.0898267806078938
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,24427,54,1.61 [1.18-2.19],0.002716378318259
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,24062,52,1.69 [0.75-3.77],0.2032257398904944
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,24062,52,1.06 [0.66-1.72],0.7975510649133498
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,24062,52,0.86 [0.47-1.57],0.6304024098035433
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,20652,46,1.05 [0.55-2.01],0.8902489078785845
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,20652,46,1.34 [0.93-1.93],0.1172864378273717
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,21142,45,1.06 [0.70-1.62],0.7824245622646626
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,24062,52,1.26 [0.78-2.03],0.3409478779735259
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,24062,52,1.23 [0.79-1.91],0.3539916664911767
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,20427,43,0.78 [0.34-1.83],0.5753674848595342
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,24340,53,2.98 [1.97-4.50],2.282811482206161e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,24062,52,1.47 [0.95-2.27],0.0841540835532784
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,21142,45,1.69 [1.14-2.51],0.0094831732599607
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,20503,43,1.18 [0.71-1.98],0.5203225655865678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,20652,46,1.13 [0.73-1.75],0.585759484276069
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,20582,46,1.28 [0.64-2.56],0.4772038809852381
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,24498,53,2.74 [1.92-3.91],3.16935881457358e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,24062,52,0.80 [0.43-1.48],0.4716104001572027
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,23893,51,1.97 [0.95-4.08],0.0695391110245367
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,20652,46,1.07 [0.69-1.68],0.752500194630316
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,20587,46,0.97 [0.63-1.50],0.9021893356510512
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,24062,52,2.27 [1.18-4.36],0.0135284928389242
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,24062,52,0.82 [0.67-1.00],0.0496646398458546
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,24498,53,4.40 [3.02-6.42],1.443702543303878e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,24062,52,1.11 [0.96-1.29],0.1641700165308379
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,24498,53,1.54 [1.02-2.34],0.0409594211539245
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,24388,52,1.37 [1.10-1.72],0.0058942666232918
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,24326,51,0.99 [0.48-2.04],0.9838112458106046
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,24516,50,5.07 [2.72-9.43],2.9883603459461295e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,24498,53,0.73 [0.50-1.07],0.1105537403083358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,24498,52,1.87 [1.15-3.04],0.0110928847850237
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,20857,43,1.09 [0.67-1.76],0.7355443983001172
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,23895,51,0.85 [0.54-1.32],0.4640643471226268
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,21142,45,1.25 [0.73-2.16],0.4177357079651679
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,24350,51,0.75 [0.49-1.14],0.1752046893039174
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,21201,45,0.87 [0.52-1.45],0.5949843970850772
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,20603,44,0.61 [0.20-1.84],0.3777889095413954
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,23883,51,1.06 [0.63-1.77],0.8300531379339492
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,20778,43,1.44 [0.84-2.47],0.1899502969462189
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,24498,52,0.62 [0.36-1.09],0.1001903424023259
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,24388,52,1.04 [0.67-1.63],0.855703027969765
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",20668,42,0.71 [0.42-1.21],0.2119158907557785
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",21225,45,0.87 [0.42-1.82],0.7112516692257458
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",24388,52,0.82 [0.63-1.05],0.1134814152100082
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,21201,45,0.82 [0.58-1.17],0.2752954262776214
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,21142,45,0.95 [0.53-1.70],0.8634218726284315
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,21166,45,0.98 [0.73-1.31],0.8768420632156044
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,20652,46,3.32 [0.66-16.74],0.1454180698222892
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,24309,51,0.69 [0.53-0.90],0.0066368847947457
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,24388,52,1.30 [0.85-1.99],0.2307757412754058
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",24076,51,1.01 [0.76-1.33],0.9536939056129894
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,24062,52,0.84 [0.58-1.20],0.335686890970321
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,24498,53,0.79 [0.64-0.99],0.0407563945713291
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,23564,51,3.10 [1.75-5.48],0.0001021952505654
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,24498,53,1.74 [0.98-3.09],0.0584789426113481
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,21251,46,0.95 [0.49-1.84],0.881668575385947
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,21015,45,0.75 [0.57-1.00],0.0479675922691655
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,24498,53,2.32 [1.25-4.30],0.0075928229663136
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,20778,43,0.59 [0.25-1.39],0.2255558651307249
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,24498,52,12.84 [6.30-26.18],2.123781837143764e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,24498,53,0.63 [0.38-1.05],0.0787700201607729
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,20652,46,1.29 [0.66-2.51],0.4539286932149213
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,24498,52,1.68 [0.80-3.51],0.1708167013004664
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,24728,54,2.26 [0.53-9.71],0.2712393300051267
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,20857,43,1.02 [0.58-1.79],0.9503126063403768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,24440,50,4.05 [2.08-7.89],4.009616500622812e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,23922,51,1.24 [0.68-2.29],0.4794904044624459
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,24076,51,0.85 [0.68-1.05],0.1254471712996061
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,24349,51,3.22 [2.02-5.13],8.432446005721228e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,24556,53,1.48 [0.84-2.61],0.1725890274709151
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,24062,52,1.33 [0.58-3.05],0.5001944176248363
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,24728,54,2.92 [1.97-4.32],8.580254127155154e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,21251,46,5.21 [3.65-7.42],8.479518010018458e-20
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,21284,46,0.63 [0.28-1.42],0.2678143032562906
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,24563,51,2.06 [1.08-3.95],0.0290201434557092
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,21284,46,0.55 [0.17-1.75],0.3116612798508915
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,21142,45,1.10 [0.59-2.04],0.772124886151297
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,24498,53,1.39 [0.94-2.05],0.1019597687693537
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,20596,45,0.69 [0.44-1.07],0.0969587859064362
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",20668,42,0.62 [0.37-1.03],0.0675029769475548
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",20603,44,0.88 [0.45-1.70],0.7039518878177164
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",23930,51,1.13 [0.70-1.83],0.6193769452116829
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,20503,43,0.57 [0.25-1.30],0.1803293441646206
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,24742,52,2.70 [1.17-6.23],0.0194679579502639
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,20778,43,0.64 [0.34-1.20],0.1645078731472249
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,24062,52,1.13 [0.75-1.70],0.5527182436974961
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,20503,43,0.63 [0.34-1.17],0.1423222113588566
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,21166,45,0.71 [0.52-0.98],0.0347188957038497
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,24062,52,1.11 [0.72-1.72],0.6282972223174474
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,24388,52,2.65 [1.50-4.66],0.0007319135813631
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,21166,45,0.73 [0.56-0.95],0.0205326834274226
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,20603,44,1.27 [0.84-1.93],0.2547572568691551
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,20673,44,0.98 [0.66-1.46],0.9208046955235204
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,23930,51,0.71 [0.38-1.32],0.2797475597749972
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,20786,45,1.44 [0.90-2.29],0.1296611438204068
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,20652,46,0.91 [0.64-1.30],0.6115559491437189
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,24556,53,0.43 [0.22-0.85],0.0156790889943629
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,23930,51,4.24 [2.24-8.00],8.55437389044504e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,20503,43,0.48 [0.24-0.95],0.0362719722058601
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,20668,42,1.20 [0.76-1.88],0.4402374648063289
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,21201,45,1.20 [0.49-2.93],0.6885947868678193
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,20857,43,1.13 [0.76-1.68],0.5518701252962843
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,20857,43,1.44 [0.55-3.78],0.4551664482622802
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,21142,45,0.68 [0.34-1.37],0.2797662712037546
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,20596,45,0.54 [0.19-1.54],0.2465765996514673
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,20603,44,1.39 [1.08-1.79],0.0099824391342008
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,20596,45,0.83 [0.66-1.04],0.1067551987870248
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,24388,52,0.75 [0.57-1.00],0.0472847252531427
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,21142,45,1.23 [0.88-1.70],0.2227510668830296
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,23922,51,1.46 [1.07-2.00],0.0170123448206741
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,21166,45,0.99 [0.84-1.17],0.8977387118216678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,23922,51,1.02 [0.83-1.25],0.8603425736008998
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,20503,43,1.01 [0.72-1.42],0.9329162163942236
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,20603,44,1.20 [0.85-1.71],0.3043934984387877
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,23930,51,2.24 [1.41-3.58],0.000690957886392
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,24534,51,0.82 [0.35-1.89],0.6333290400723552
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,24516,50,0.60 [0.43-0.85],0.0037214302938474
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,23930,51,1.32 [0.95-1.84],0.097020763007588
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,20603,44,1.12 [0.56-2.22],0.7451894750281061
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,21225,45,1.44 [0.97-2.13],0.0724650169653971
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,24251,51,1.11 [0.93-1.34],0.2546542619214372
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,24483,53,1.57 [0.89-2.77],0.1195794075123989
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,24307,53,1.93 [1.01-3.71],0.0467883608444979
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,23922,51,1.02 [0.85-1.22],0.8472907394335438
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,23935,51,0.50 [0.28-0.88],0.0160069230260167
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,24728,54,0.85 [0.51-1.43],0.5461019585574307
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,21109,45,0.78 [0.44-1.38],0.3874820829580276
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,21251,46,0.83 [0.58-1.17],0.2861934959748788
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,24728,54,1.04 [0.71-1.54],0.8328416895587012
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,24521,53,1.27 [0.57-2.86],0.5555958561653451
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,20231,41,0.35 [0.16-0.79],0.0112020926030202
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,23654,50,1.05 [0.52-2.15],0.8848276217220326
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,20881,45,0.54 [0.30-0.98],0.0421673058720574
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,24807,53,3.27 [1.82-5.87],7.473363838468277e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,20603,44,0.74 [0.40-1.35],0.3260969137071311
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,24807,53,1.46 [0.87-2.43],0.1510988386650227
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,20652,46,0.93 [0.48-1.80],0.8212470277605994
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,21201,45,0.79 [0.43-1.44],0.4389224138224358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",23177,51,0.61 [0.23-1.60],0.3187050864923516
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",20596,45,0.52 [0.23-1.18],0.119116720729913
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",24388,52,1.69 [1.35-2.10],3.1160616197797776e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",24469,53,1.95 [1.45-2.62],1.1124349779976764e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",23930,51,0.94 [0.56-1.55],0.796253199623485
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",20596,45,1.11 [0.58-2.15],0.7469899493691362
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",20603,44,1.36 [1.08-1.72],0.0100796691206757
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,24466,50,1.28 [0.84-1.95],0.2579265079735642
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,24807,53,1.29 [0.79-2.13],0.3105552983725543
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,24556,53,3.20 [1.42-7.20],0.0049394862697377
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,21259,46,0.78 [0.57-1.07],0.1223622341619949
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,21105,45,1.10 [0.62-1.95],0.7535222252932448
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,24516,50,0.72 [0.49-1.06],0.0924032617987665
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,24388,52,2.26 [1.70-3.01],2.444535058684129e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,24483,54,1.96 [1.27-3.03],0.0023600864834532
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,24350,51,1.19 [0.92-1.54],0.1749962783052358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,20596,45,0.89 [0.50-1.61],0.7069001844171063
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,24603,54,1.71 [0.92-3.19],0.0914827556113759
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,20668,42,2.28 [0.87-5.99],0.0955030199151243
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,20676,44,0.42 [0.12-1.47],0.1743925272935279
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,23767,49,1.42 [0.39-5.18],0.5976518655375951
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,24759,53,1.57 [1.01-2.44],0.0455328539004822
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,21142,45,1.28 [0.71-2.31],0.4207587654696728
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,24062,52,1.22 [0.74-1.99],0.4377339517145003
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,21142,45,0.53 [0.30-0.93],0.0275667282988643
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,24807,53,0.75 [0.56-1.01],0.0555921934230775
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,24388,52,0.84 [0.69-1.03],0.0957119517951297
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,20652,46,0.65 [0.46-0.92],0.0150929233525796
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,24303,51,3.07 [1.72-5.47],0.0001436734067618
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,24563,51,1.11 [0.73-1.68],0.6270478061287776
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,24742,52,0.90 [0.63-1.31],0.5937342548887634
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,21264,46,0.64 [0.33-1.23],0.1789321495833603
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,21225,45,0.97 [0.60-1.55],0.8941605830374559
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,23724,50,0.92 [0.46-1.82],0.8072409807162363
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,21251,46,0.90 [0.50-1.61],0.7155460288056559
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,24565,53,1.21 [0.77-1.91],0.4032708167232824
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,21225,45,0.75 [0.57-1.00],0.0509550110068991
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,21259,46,0.86 [0.55-1.34],0.4960970225302668
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,24696,54,1.45 [0.93-2.27],0.0987314488994388
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,20036,41,1.23 [0.82-1.84],0.3074557983231247
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,20603,44,1.03 [0.69-1.53],0.8818689734556233
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,21225,45,2.03 [1.33-3.10],0.0010096774872731
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LEP,Leptin,24516,50,1.02 [0.71-1.49],0.8976344899751775
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,24516,50,2.29 [1.28-4.09],0.0052561321808413
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,21225,45,1.01 [0.59-1.71],0.980441464410054
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,24516,50,1.39 [0.68-2.86],0.3658520398026383
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,24561,52,1.09 [0.48-2.49],0.829629783043813
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,21284,46,3.06 [2.18-4.28],8.462971411234493e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,24483,54,2.08 [1.43-3.04],0.0001405397648883
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,24474,54,0.87 [0.48-1.60],0.663213257192715
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,24742,52,0.61 [0.39-0.93],0.0228117035704452
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,24480,54,4.24 [2.29-7.85],4.420938764870263e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,24603,54,1.81 [0.97-3.35],0.0603298578702385
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,23922,51,1.01 [0.77-1.34],0.9262250512584512
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,24515,54,1.33 [0.91-1.95],0.1380836428162327
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,23930,51,1.50 [1.09-2.07],0.0123528773811997
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,24498,53,4.67 [2.61-8.35],1.9497489287853465e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,24498,52,2.15 [1.05-4.39],0.0359100637454221
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,21251,46,0.83 [0.73-0.95],0.0072527840666736
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,20596,45,1.45 [0.97-2.17],0.0683784656874699
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,24488,50,1.59 [0.73-3.43],0.2403014282067375
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,21259,46,1.37 [0.93-2.00],0.110260096936146
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,24801,53,2.31 [0.98-5.44],0.0546352841449697
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,24663,52,1.57 [0.77-3.21],0.2166175677777889
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,24062,52,1.64 [0.94-2.87],0.0795367952472813
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,24801,53,1.53 [1.03-2.28],0.0357569778734613
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,20668,42,0.84 [0.50-1.38],0.4861474200334585
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,21121,45,1.06 [0.70-1.62],0.7823955866701189
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,21201,45,1.95 [0.83-4.58],0.1248463239906225
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,21225,45,0.95 [0.41-2.22],0.9046906992597408
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,20603,44,0.87 [0.53-1.44],0.593301183582785
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",20668,42,0.88 [0.63-1.24],0.4750988446293754
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),20770,45,0.83 [0.70-0.97],0.0180344283210969
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,24388,52,1.19 [0.78-1.81],0.4158824214688433
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,24516,50,1.30 [0.76-2.21],0.3325672986159544
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,23734,50,1.43 [0.97-2.12],0.0730935417587131
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,20596,45,0.69 [0.44-1.07],0.0930574754956889
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,20596,45,0.76 [0.49-1.18],0.2257152580708159
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,20673,44,1.17 [0.72-1.91],0.5310735478699099
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,21284,46,0.59 [0.20-1.73],0.3377020408834263
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,24665,54,1.07 [0.54-2.15],0.8386016545175707
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,20581,46,0.94 [0.33-2.66],0.9024843562913688
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,24388,52,2.28 [0.98-5.30],0.0552485231526694
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,24516,50,1.89 [0.97-3.71],0.0631019912835166
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,20673,44,1.47 [0.79-2.72],0.2267454569142307
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,20673,44,0.96 [0.66-1.39],0.8191869613981567
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,24742,52,0.97 [0.62-1.52],0.8888770318970853
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,24388,52,2.04 [1.33-3.13],0.001077654540614
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,21166,45,1.39 [0.72-2.71],0.3275454036671776
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,20673,44,0.58 [0.29-1.13],0.1091275966025391
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,21259,46,0.65 [0.34-1.26],0.200837708781354
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,21142,45,0.61 [0.32-1.18],0.1454455443492221
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,24062,52,0.77 [0.41-1.43],0.4017533128969756
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,20673,44,0.70 [0.32-1.56],0.3860449416793353
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,21225,45,1.81 [0.79-4.15],0.163174420945889
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,23922,51,1.11 [0.74-1.67],0.602843071978505
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,20857,43,1.12 [0.83-1.50],0.4576927978902568
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,24498,53,1.13 [0.63-2.03],0.6867184347187018
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,24498,53,1.74 [1.02-2.95],0.0404419603784103
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,24728,54,1.32 [0.91-1.89],0.1409307405207311
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,21142,45,1.70 [1.06-2.72],0.0268068274956835
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,24801,53,8.12 [5.18-12.72],5.67792985786742e-20
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,23922,51,1.60 [1.20-2.13],0.001368763800117
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,24344,54,4.44 [2.31-8.52],7.835316677037766e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,24062,52,1.52 [1.02-2.28],0.0416525806940225
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,21142,45,1.02 [0.54-1.94],0.9494853476882834
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LXN,Latexin,24233,51,1.23 [0.88-1.72],0.2349487716250411
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,24343,54,0.85 [0.43-1.67],0.6344772959382519
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,24498,53,5.27 [2.62-10.62],3.2854744752468106e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,24271,52,5.10 [2.44-10.66],1.466834644639687e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,24350,51,2.41 [1.49-3.90],0.0003346168059198
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,23922,51,1.16 [0.78-1.71],0.4606516089470326
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,24388,52,0.75 [0.57-0.99],0.0427551702916684
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,23930,51,1.07 [0.75-1.53],0.7124660777190162
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,24371,53,1.58 [0.78-3.17],0.2018811917423722
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,23922,51,1.44 [1.00-2.06],0.0498088483374087
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,20603,44,0.91 [0.67-1.23],0.5465446697361621
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,20673,44,0.96 [0.71-1.29],0.7766729435936959
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,21284,46,3.59 [0.91-14.16],0.0675469409851693
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,20503,43,0.69 [0.28-1.69],0.4216876860366239
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,20778,43,0.63 [0.41-0.96],0.0317039794811372
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,20668,42,0.80 [0.35-1.82],0.588581848257806
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,24272,51,1.43 [1.04-1.95],0.0262510968705911
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,23922,51,1.51 [0.96-2.36],0.0715855753214548
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,20673,44,0.80 [0.44-1.48],0.4823913432177393
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,20857,43,0.94 [0.67-1.32],0.7319198638983404
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,23922,51,0.70 [0.40-1.22],0.2120995240382168
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,21259,46,4.12 [2.13-7.99],2.7783120123355207e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,21142,45,1.16 [0.71-1.90],0.5448931732555031
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",20668,42,1.63 [0.51-5.20],0.409938710940446
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,21259,46,1.34 [0.83-2.15],0.2313361365342052
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",20503,43,1.60 [1.04-2.45],0.0323165775081159
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,24603,54,0.85 [0.71-1.02],0.0774544433541277
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,24556,53,3.50 [1.58-7.77],0.0020627113683665
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,20596,45,1.37 [0.93-2.03],0.1137914874159719
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,20603,44,0.67 [0.27-1.68],0.3961459668508773
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,20596,45,1.36 [1.01-1.82],0.0396955061239844
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,21201,45,0.55 [0.26-1.13],0.1031281904364497
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,21166,45,0.80 [0.51-1.24],0.3109172506797507
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,24498,53,0.78 [0.61-0.98],0.0364988064756457
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,23922,51,0.96 [0.74-1.25],0.7626788631253556
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,24303,51,0.80 [0.65-1.00],0.0489671626546188
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,20503,43,1.38 [0.86-2.22],0.1844502956849521
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,24498,53,1.04 [0.59-1.82],0.8981291832486665
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,20857,43,0.68 [0.46-1.03],0.0664402513702079
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,20503,43,0.88 [0.68-1.13],0.3096921630970378
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,23930,51,0.93 [0.59-1.48],0.758677331424705
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,24516,50,2.58 [0.99-6.73],0.0520745114491399
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",20731,42,0.74 [0.52-1.06],0.0974471329835691
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,24303,51,3.49 [1.21-10.07],0.0204689932680625
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,24527,54,5.00 [2.38-10.49],2.111974786962864e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,24309,51,1.28 [0.59-2.78],0.5275655641579925
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,23922,51,0.90 [0.68-1.20],0.482879335643303
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAX,Protein max,23930,51,0.86 [0.67-1.09],0.2089675864140268
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,24801,53,1.16 [0.76-1.78],0.4842247678062732
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,20984,45,1.31 [1.00-1.73],0.050605412697663
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,24563,51,2.38 [1.25-4.52],0.0081758731747154
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",21225,45,1.10 [0.59-2.05],0.763566679155402
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,20652,46,0.76 [0.55-1.07],0.1188954802138215
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,24408,50,0.71 [0.40-1.25],0.2384434530149964
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,21166,45,0.67 [0.19-2.35],0.5362267729340648
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,24350,51,1.49 [1.04-2.12],0.0290102680007019
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",21140,45,0.61 [0.29-1.29],0.1929995024400557
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MDK,Midkine,24476,53,1.25 [0.82-1.91],0.2905990701799028
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,20673,44,0.47 [0.18-1.24],0.1278183940208179
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",20668,42,0.85 [0.62-1.18],0.3349672858414327
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,23922,51,0.81 [0.58-1.11],0.1917220939449067
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,20596,45,1.20 [0.73-1.95],0.4716045167570373
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,24483,54,1.34 [0.74-2.44],0.3368539585883006
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,20596,45,1.95 [1.16-3.27],0.0118631374810202
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,24711,53,2.28 [0.94-5.52],0.0677098443170887
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,21259,46,1.11 [0.43-2.88],0.8279028982266718
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,20778,43,0.34 [0.18-0.65],0.001227470221652
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,21166,45,0.99 [0.67-1.45],0.941367309973579
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,24516,50,1.04 [0.84-1.29],0.7379733549542151
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,24483,54,1.57 [0.57-4.33],0.3810336628105898
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,24807,53,4.72 [2.04-10.93],0.000285980264498
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,24498,52,0.79 [0.65-0.96],0.0203468788187968
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,24558,53,2.18 [0.64-7.42],0.2103785462614617
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,23930,51,1.09 [0.49-2.42],0.833210345437378
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",24498,53,0.91 [0.68-1.21],0.505340810397575
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,24696,54,0.87 [0.58-1.31],0.4946052901800892
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,24076,51,1.34 [0.90-2.00],0.1482538310695308
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,20673,44,0.94 [0.59-1.49],0.8020435964918387
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,20778,43,5.20 [2.34-11.51],4.9184210647805855e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,24801,53,0.74 [0.41-1.33],0.3186500898193529
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,24498,52,1.10 [0.65-1.86],0.7301745565460684
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,24568,54,0.73 [0.57-0.94],0.0151737186765945
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,24498,53,0.88 [0.73-1.06],0.1875934202960154
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,24556,53,0.68 [0.36-1.29],0.237633152159873
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,20673,44,0.73 [0.44-1.21],0.219188965153477
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,24498,53,1.12 [0.92-1.35],0.2675832160382105
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,24454,51,0.83 [0.58-1.18],0.2991883380437815
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,24062,52,2.26 [1.54-3.30],2.6865855095111205e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,21142,45,0.81 [0.62-1.04],0.0978579299124186
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,21201,45,0.77 [0.57-1.04],0.0878491176518233
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,24350,51,0.71 [0.56-0.91],0.0060627276028373
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,20652,46,0.93 [0.45-1.91],0.8452275410535961
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,20503,43,0.91 [0.59-1.42],0.682885239335983
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,24498,53,0.86 [0.66-1.13],0.282104216074119
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,24388,52,1.84 [1.41-2.39],5.172020752664236e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,23638,50,0.84 [0.64-1.10],0.2164518044690026
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,24459,53,1.29 [0.87-1.93],0.2032305590104656
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,24551,53,2.00 [1.31-3.04],0.0012065986158285
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,23930,51,1.51 [0.69-3.30],0.3037270962824813
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,21259,46,1.22 [0.81-1.85],0.3454794910989133
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,24498,52,0.93 [0.55-1.55],0.7704046940167733
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,24037,51,3.26 [1.98-5.38],3.707001221409896e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,24704,52,0.84 [0.60-1.17],0.2986364511986788
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,24465,52,0.81 [0.54-1.20],0.2897480721102947
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",20596,45,1.30 [0.79-2.14],0.3043818679317359
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,20673,44,0.47 [0.24-0.95],0.0346451971697785
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,20857,43,0.39 [0.17-0.90],0.0275483127640402
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,24481,50,0.98 [0.77-1.26],0.8798683840855775
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,20778,43,0.80 [0.51-1.25],0.3311520623979492
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,24728,54,0.88 [0.42-1.83],0.7283712518671617
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,21201,45,0.45 [0.13-1.53],0.2015144461054107
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,20857,43,1.12 [0.58-2.15],0.7358207890549975
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,20503,43,0.92 [0.41-2.07],0.8366240758206845
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,20503,43,0.92 [0.63-1.36],0.6810492094979009
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,24076,51,0.81 [0.57-1.14],0.2285794681271754
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,24388,52,0.89 [0.67-1.19],0.4316410287843492
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,24568,54,0.66 [0.51-0.85],0.0016636800561248
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,24498,52,0.99 [0.58-1.68],0.9659079237388728
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,21107,45,0.73 [0.38-1.42],0.3585474412387351
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,21264,46,5.32 [2.47-11.47],1.971215222266445e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,20673,44,0.84 [0.55-1.29],0.4312934721280725
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",20596,45,0.59 [0.24-1.47],0.2583521276617795
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",21225,45,1.41 [0.90-2.19],0.1308963230868844
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",23930,51,0.58 [0.22-1.57],0.2832946370571839
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",20467,43,1.30 [0.42-3.97],0.6465456925075597
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",21225,45,0.45 [0.25-0.81],0.0078071898030457
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",20652,46,0.78 [0.27-2.30],0.6564611132248035
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,24357,52,1.20 [0.80-1.81],0.3741219568679566
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,20673,44,1.09 [0.50-2.37],0.819601915711301
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,24428,50,1.04 [0.72-1.50],0.8261718948505445
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,24742,52,2.49 [1.55-4.00],0.000173380942622
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,24556,53,0.85 [0.61-1.18],0.3209817362328853
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,20958,46,0.87 [0.61-1.24],0.4537946878866681
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,24076,51,0.88 [0.55-1.41],0.5944672132818036
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,20652,46,0.79 [0.58-1.08],0.1427588184849417
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",21201,45,0.52 [0.14-1.90],0.3204405050159981
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,20857,43,0.79 [0.61-1.03],0.0808727173372481
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",21166,45,0.67 [0.48-0.94],0.0187625808821399
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,24076,51,1.37 [0.78-2.41],0.2685424193958445
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,20596,45,1.23 [0.86-1.75],0.2638138232953612
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,21166,45,0.85 [0.66-1.09],0.1954050573342719
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,21142,45,0.75 [0.56-1.00],0.0521407857307065
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,20857,43,1.63 [1.14-2.32],0.0068668168121548
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,23930,51,3.21 [2.32-4.45],2.001092064570685e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,24388,52,1.07 [0.93-1.23],0.337708901591314
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,21251,46,1.25 [0.93-1.68],0.1455939577260558
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,20503,43,0.80 [0.37-1.75],0.583953146038691
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,24062,52,1.17 [0.87-1.56],0.2993669504971697
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,20778,43,2.20 [0.85-5.67],0.1027087010223627
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",21259,46,0.98 [0.65-1.45],0.9019729239884448
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",20668,42,0.79 [0.52-1.21],0.2810271935434321
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,21225,45,0.60 [0.36-1.01],0.0527350932479924
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,21259,46,0.73 [0.55-0.97],0.0317641402735516
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,20596,45,1.15 [0.67-1.99],0.6099258658167406
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,20503,43,0.72 [0.33-1.56],0.4003778849852052
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,21251,46,0.76 [0.59-0.98],0.0329911275981632
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",20596,45,0.96 [0.47-1.96],0.9045950287163133
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,20668,42,0.89 [0.59-1.34],0.5874211423042939
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,20668,42,1.62 [1.06-2.49],0.0257109252593025
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,20673,44,0.82 [0.56-1.20],0.3121267605007285
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",20673,44,0.71 [0.34-1.47],0.358430267228767
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,21225,45,1.01 [0.49-2.11],0.9753288161648171
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,24062,52,1.01 [0.70-1.46],0.9728467954792794
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,24498,52,1.72 [1.01-2.93],0.0461407986269071
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,20603,44,1.14 [0.67-1.97],0.6252518276135473
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,20596,45,0.91 [0.51-1.63],0.7579648732908504
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,20778,43,0.83 [0.61-1.14],0.2564925199845261
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,24562,54,1.95 [1.28-2.97],0.0018224403370963
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,23922,51,1.53 [1.07-2.20],0.0204071316881492
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,20596,45,0.55 [0.33-0.93],0.0249582836151703
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,20673,44,0.74 [0.58-0.94],0.0149189403499221
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,24240,51,1.10 [0.73-1.65],0.6482079702420822
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,21142,45,0.93 [0.54-1.59],0.7847683021402119
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,24516,50,0.99 [0.64-1.53],0.9580760448185353
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,20618,46,0.77 [0.42-1.41],0.3899906205950626
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,20630,42,0.83 [0.49-1.41],0.489684690816668
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,20778,43,1.74 [0.45-6.73],0.424520233409338
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,23922,51,1.13 [0.76-1.68],0.5342578173142289
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,21130,45,0.75 [0.40-1.39],0.3586082142427753
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,21201,45,0.78 [0.31-1.96],0.5916770137519679
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",21225,45,0.61 [0.35-1.08],0.0887740069589567
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,24556,53,2.11 [0.86-5.21],0.1045108508152911
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,24062,52,1.31 [0.95-1.81],0.1003719652682466
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,24563,51,0.70 [0.31-1.57],0.383329023610255
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,24498,52,1.72 [0.69-4.24],0.2424867451414887
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,24742,52,1.44 [0.75-2.77],0.2762257317031845
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,24457,53,1.13 [0.88-1.46],0.3477577551021364
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,24603,54,0.80 [0.64-1.00],0.0461557383229703
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,24062,52,0.75 [0.40-1.40],0.3674906241996039
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,24465,53,2.00 [1.05-3.84],0.0360015477052483
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,21166,45,4.54 [2.62-7.87],6.757261201846148e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,24728,54,1.04 [0.44-2.45],0.9319563969496708
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,23930,51,1.25 [0.97-1.60],0.0828373792061318
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,21142,45,0.93 [0.57-1.50],0.7619378907731426
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,20607,46,0.66 [0.30-1.48],0.3163300394101315
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,21166,45,0.65 [0.47-0.91],0.010904697410659
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",23922,51,0.85 [0.59-1.22],0.3686905993310041
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,20596,45,1.91 [1.20-3.03],0.0059475133776709
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,20596,45,0.74 [0.45-1.21],0.2258916496780111
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,20652,46,1.29 [0.59-2.79],0.5249471803513706
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,24488,50,4.23 [2.08-8.59],6.527142462975893e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,24556,53,2.11 [1.05-4.23],0.0358673751511503
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,20652,46,1.18 [0.64-2.16],0.5952964650230383
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,20652,46,0.68 [0.27-1.75],0.4290922467031913
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,23852,50,1.12 [0.63-1.99],0.7080512030810422
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,20857,43,0.80 [0.50-1.27],0.338451273472739
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,24556,53,1.07 [0.60-1.90],0.8262623531206825
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,24603,54,5.47 [2.85-10.48],3.0501516030163805e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,21142,45,0.98 [0.75-1.28],0.864486139896048
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,21225,45,1.07 [0.31-3.71],0.9126816683999448
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,21264,46,0.59 [0.38-0.93],0.023006440750774
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,24807,53,14.87 [7.92-27.94],4.719363580161685e-17
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,20652,46,0.89 [0.62-1.26],0.5044309020492006
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",24498,53,0.79 [0.62-1.02],0.0743672040651764
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",24062,52,1.49 [1.05-2.11],0.0242234698301138
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,20668,42,0.76 [0.50-1.15],0.1924456528926539
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,21225,45,1.06 [0.55-2.03],0.8711915572181386
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,20596,45,0.62 [0.42-0.93],0.0205027382075513
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,20857,43,0.88 [0.48-1.60],0.6753028206965397
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,23922,51,1.18 [0.72-1.94],0.5101069347778182
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",21166,45,0.81 [0.62-1.06],0.1294794009226983
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,20596,45,0.58 [0.36-0.94],0.0266385190028238
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,20596,45,0.94 [0.44-2.01],0.87252437051109
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,24350,51,0.78 [0.10-5.96],0.8105097665547274
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,21259,46,1.62 [0.84-3.14],0.1520900388624526
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,21201,45,0.44 [0.10-1.90],0.2694608292790663
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,20293,41,3.03 [1.15-7.94],0.0243275210659008
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,24492,51,1.05 [0.56-2.00],0.8704427264397875
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,24498,52,0.90 [0.65-1.25],0.5248567896522606
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,23922,51,1.10 [0.73-1.66],0.651149223897046
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,20668,42,0.56 [0.32-0.98],0.0428375709146869
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,21182,46,0.83 [0.57-1.21],0.3241079415753142
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,20673,44,1.24 [0.90-1.72],0.1906599170085355
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,20603,44,1.04 [0.57-1.92],0.89120652283479
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,20652,46,0.90 [0.24-3.43],0.8796383900142217
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,24527,54,2.78 [1.46-5.26],0.0017768246002143
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,21055,45,1.09 [0.74-1.60],0.6556627114558542
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,24350,51,1.21 [0.93-1.57],0.1614125511128704
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,20503,43,0.99 [0.48-2.03],0.9687405452235006
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,21225,45,0.56 [0.32-0.96],0.0366509531600787
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,24498,52,3.08 [1.56-6.07],0.0011638849062726
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,20596,45,1.03 [0.80-1.32],0.8118570954172591
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",23930,51,1.02 [0.64-1.60],0.9467329942332988
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",20596,45,2.10 [1.25-3.51],0.0049467028978438
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",23930,51,1.22 [0.79-1.90],0.373251367602033
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,24801,53,20.50 [8.41-49.93],2.9515460195744144e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,21251,46,2.03 [0.65-6.30],0.2220824812408988
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,24801,53,5.61 [3.23-9.74],8.96931736192765e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,20898,44,2.14 [1.18-3.87],0.0120106422724489
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,24516,50,2.20 [1.19-4.07],0.0121732932562214
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,20652,46,0.56 [0.23-1.35],0.1939199613860109
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,20652,46,1.18 [0.94-1.48],0.1572994324609432
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,21259,46,1.27 [0.69-2.33],0.4343615498592567
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,24076,51,0.95 [0.79-1.14],0.5920994601387657
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,24498,53,1.24 [0.77-1.99],0.3767396602811135
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,20596,45,1.39 [0.77-2.51],0.2733557566665888
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,23922,51,1.13 [0.88-1.46],0.3420806913206952
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,24498,52,2.86 [1.84-4.45],3.127392240772218e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,21251,46,2.62 [1.18-5.85],0.0184171003008396
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,24516,50,1.65 [0.89-3.05],0.1121126980037946
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,24728,54,0.79 [0.56-1.12],0.1890322411519295
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,24516,50,3.48 [1.60-7.58],0.0016545196328421
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,21264,46,0.73 [0.53-0.98],0.0392528337511505
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,21225,45,0.79 [0.31-2.00],0.6200563643246333
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,24616,51,3.04 [1.34-6.92],0.0079360170378836
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,24498,52,3.92 [2.36-6.52],1.327172265060726e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,24062,52,0.77 [0.46-1.31],0.3413705393719498
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,20673,44,0.55 [0.19-1.58],0.2677588453122989
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,24742,52,0.87 [0.60-1.26],0.4608401832071008
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",21259,46,0.85 [0.59-1.22],0.3725164851341435
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,21201,45,1.16 [0.51-2.66],0.7197339607904198
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,24455,53,0.92 [0.70-1.20],0.5317812315302628
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,24556,53,2.30 [1.68-3.14],1.8640872242147058e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,24498,53,1.07 [0.54-2.11],0.8470933768145644
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,23922,51,1.50 [1.06-2.13],0.0208315368516206
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,24516,50,0.91 [0.34-2.41],0.8495322996596856
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,24742,52,1.16 [0.38-3.58],0.793083509838326
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,24516,50,1.19 [0.93-1.52],0.1569335017839365
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,24498,53,0.79 [0.58-1.07],0.1319129504009547
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,21142,45,0.89 [0.65-1.22],0.459239800504549
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,24693,54,0.71 [0.37-1.38],0.3153858257854688
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,24807,53,0.67 [0.47-0.97],0.0317789022064631
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,20668,42,1.65 [0.81-3.35],0.1640584784505911
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,20596,45,0.87 [0.46-1.66],0.6813598102498355
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,21134,45,0.82 [0.59-1.13],0.2267041136737735
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],24388,52,0.83 [0.53-1.30],0.4198259069556669
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,24498,52,0.80 [0.49-1.30],0.3710019967723506
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,20652,46,0.63 [0.45-0.88],0.0068357372612592
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,20596,45,1.16 [0.52-2.59],0.721915801731625
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,20596,45,1.31 [0.66-2.60],0.4484497072482806
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,23930,51,0.65 [0.33-1.28],0.2129359496421496
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,20652,46,0.63 [0.25-1.59],0.3291798555447415
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,24269,51,0.84 [0.57-1.23],0.3720601613231297
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,21225,45,2.62 [1.58-4.33],0.0001813225501442
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,23893,51,0.71 [0.42-1.21],0.2088465017703609
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,20857,43,0.70 [0.39-1.26],0.2314060727222798
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,21166,45,0.71 [0.47-1.08],0.1071080498001864
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,24388,52,1.01 [0.47-2.17],0.9795870020676436
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,24498,52,0.88 [0.47-1.63],0.6760990926551215
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,20857,43,1.08 [0.71-1.65],0.7261491854940331
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,20014,41,1.05 [0.82-1.34],0.7273362664104589
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,24268,50,0.99 [0.65-1.49],0.9504658705210888
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,24603,54,3.60 [1.99-6.54],2.427935457145972e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,24388,52,1.33 [0.92-1.91],0.1274423880026693
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,20603,44,0.64 [0.31-1.31],0.219763249489827
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,21201,45,0.79 [0.61-1.03],0.0782668941526132
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,20668,42,0.87 [0.56-1.35],0.5263929540140617
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,24388,52,1.69 [1.21-2.37],0.0023473050509501
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,21210,46,0.66 [0.32-1.38],0.2719802846511661
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,21201,45,0.76 [0.32-1.86],0.553455689350854
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,24527,54,3.04 [1.49-6.20],0.0023144609230821
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,24367,53,0.81 [0.58-1.13],0.2149286115438642
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,24616,51,10.69 [5.02-22.78],8.173078015770782e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,20673,44,1.19 [0.67-2.09],0.5571314643576899
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,20603,44,1.23 [0.79-1.92],0.3495935696539201
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,21166,45,0.71 [0.43-1.17],0.1794658319915637
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,21225,45,0.74 [0.47-1.18],0.2054138494173675
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",20668,42,0.74 [0.48-1.16],0.1923095744604224
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,24742,52,1.10 [0.93-1.31],0.2589716932960508
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,24363,52,1.10 [0.59-2.05],0.7570380954776617
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,20596,45,0.64 [0.39-1.05],0.0798011359181005
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,24062,52,1.21 [0.87-1.70],0.2545127670675092
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,23893,51,0.90 [0.62-1.28],0.5468135238287508
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,24350,51,1.12 [0.93-1.34],0.2251989697777539
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,21225,45,0.95 [0.73-1.23],0.6915302761003164
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",20857,43,0.83 [0.45-1.54],0.560483870211864
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,24076,51,0.84 [0.53-1.32],0.4484747464721099
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,20668,42,0.67 [0.32-1.43],0.3016000678683528
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,20460,43,1.11 [0.65-1.89],0.6915945203099853
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,23930,51,0.77 [0.49-1.19],0.2321706597164552
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,20652,46,0.57 [0.23-1.41],0.2221349160015134
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,21051,45,0.98 [0.38-2.55],0.9706384915242524
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,21201,45,2.52 [1.57-4.06],0.0001380618377935
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,20596,45,1.31 [1.02-1.69],0.0355493346987558
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,24673,52,6.74 [3.16-14.39],8.125649057933802e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,24498,52,0.58 [0.25-1.38],0.2220002549294161
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,24062,52,1.86 [1.15-3.01],0.0109671888632099
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,20857,43,0.97 [0.64-1.45],0.8680013255122734
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,24498,52,0.73 [0.45-1.17],0.1856678003478621
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,24498,53,1.34 [1.00-1.78],0.0488831013297779
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,20778,43,0.80 [0.42-1.54],0.5041397935444616
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,20503,43,2.13 [0.88-5.15],0.0926853055321001
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,23930,51,1.27 [0.82-1.98],0.2862429213243019
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,21166,45,0.43 [0.15-1.19],0.1054685086738027
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,20603,44,0.71 [0.44-1.14],0.1567622359338556
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,20728,43,1.60 [0.97-2.63],0.0638804129221299
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,21225,45,0.66 [0.45-0.99],0.042169264870529
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,24724,53,2.26 [1.05-4.83],0.036288238854628
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,21225,45,3.83 [2.36-6.22],5.220674136826455e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,24516,50,4.86 [2.85-8.28],5.782351361725871e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,21166,45,1.78 [1.07-2.97],0.0261856620926167
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,21166,45,2.54 [1.11-5.83],0.0277156846144039
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,21142,45,1.86 [1.11-3.11],0.0186885525025983
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,20503,43,0.96 [0.60-1.51],0.8446668970989556
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,21142,45,0.86 [0.44-1.67],0.6584439148687045
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,24801,53,1.32 [0.72-2.41],0.3738801378959715
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,21166,45,0.77 [0.54-1.12],0.1752445509608061
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,21259,46,0.74 [0.55-0.98],0.0377902913388385
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,24692,53,2.51 [1.57-4.02],0.000125935296214
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,24388,52,1.66 [0.78-3.55],0.1894906136036018
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,24742,52,0.98 [0.64-1.48],0.9077720433378548
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,24516,50,1.35 [0.86-2.12],0.1954566526522254
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,20503,43,0.77 [0.39-1.49],0.4353206832481799
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",20503,43,0.59 [0.27-1.27],0.1780622810319426
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",20596,45,0.85 [0.49-1.48],0.5720512065666905
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",20778,43,0.78 [0.60-1.01],0.0627737822794608
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,24801,53,0.82 [0.59-1.13],0.2199034953866146
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,24603,54,0.83 [0.64-1.09],0.1806481061446116
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,23922,51,0.56 [0.23-1.35],0.1957173755840533
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,24516,50,5.10 [3.15-8.25],3.0565014647055134e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,24801,53,1.61 [0.80-3.27],0.1840876303385692
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,20503,43,1.18 [0.60-2.33],0.6360865399529632
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,20778,43,0.88 [0.27-2.90],0.8306707363387176
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,21251,46,0.62 [0.38-1.02],0.0574856660033623
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,20503,43,1.34 [0.94-1.90],0.110365751366922
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,21225,45,0.78 [0.62-0.98],0.030116100465457
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,24603,54,0.88 [0.72-1.06],0.1779832446990815
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",23922,51,1.04 [0.65-1.66],0.8792936558220794
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,20673,44,0.64 [0.32-1.28],0.2075875741948699
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,20503,43,1.44 [1.09-1.90],0.0107712038348559
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,20596,45,0.93 [0.56-1.55],0.7900880642869477
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,20652,46,2.12 [1.44-3.10],0.0001182380911631
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,24801,53,2.92 [1.01-8.45],0.0488184893429215
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,24498,52,0.80 [0.52-1.24],0.3211591021560178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,24498,52,1.87 [0.87-4.05],0.1093565119480464
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,20668,42,1.02 [0.37-2.80],0.9717818591622792
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,20778,43,0.37 [0.13-1.07],0.0656952542354162
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,21264,46,0.71 [0.25-2.05],0.5278113628979264
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,20652,46,0.82 [0.64-1.06],0.1313078280532292
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,21122,45,0.65 [0.49-0.87],0.0030845758319421
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,23930,51,1.00 [0.63-1.57],0.9903292720910916
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,20503,43,1.09 [0.68-1.77],0.7117092844143201
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,20673,44,1.22 [0.87-1.71],0.2530765765049119
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",24354,52,0.88 [0.64-1.22],0.4448691795756756
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,21264,46,0.84 [0.56-1.26],0.4006120090062682
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",21259,46,0.98 [0.59-1.65],0.9498527572395284
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,24807,53,2.58 [1.61-4.12],7.681582595758827e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,24663,52,1.06 [0.60-1.88],0.8375433724862769
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,21007,45,0.46 [0.19-1.12],0.0888532175805165
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,20596,45,1.43 [1.04-1.97],0.0275902443970424
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,20673,44,0.94 [0.56-1.58],0.8198229286477988
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,20652,46,0.83 [0.57-1.20],0.3184169560354486
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,21225,45,0.76 [0.59-0.97],0.0253999586833294
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,21166,45,1.22 [0.71-2.08],0.4684376513379169
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,20503,43,1.07 [0.80-1.43],0.6445377989481921
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,24350,51,1.04 [0.44-2.41],0.935715228638472
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,20778,43,0.92 [0.46-1.84],0.8099047549241936
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,21264,46,0.70 [0.22-2.17],0.5346911893396238
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PI3,Elafin,24160,52,0.74 [0.45-1.21],0.2312938161801265
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",21225,45,0.72 [0.50-1.06],0.0928316243100336
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,24193,48,4.30 [2.67-6.93],1.9948175283175915e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,24498,53,1.14 [0.77-1.67],0.5179948780572512
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,24498,52,3.08 [1.50-6.33],0.0021283895649678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,20652,46,0.79 [0.45-1.40],0.421074027998585
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,24498,52,3.43 [1.99-5.91],9.325585831978814e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,24516,50,2.81 [1.69-4.67],6.633990699367502e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,20778,43,0.83 [0.55-1.26],0.3812691510432286
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,20460,43,1.14 [0.83-1.57],0.4103109184782734
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,21259,46,9.57 [3.78-24.21],1.86393126974189e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,20596,45,0.68 [0.39-1.18],0.1698862091097243
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,24517,54,1.47 [1.05-2.04],0.0227717299923277
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,20857,43,0.69 [0.46-1.05],0.0871533881746332
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,24350,51,1.78 [1.18-2.69],0.0059328672698068
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,24556,53,7.17 [3.84-13.41],6.674082913204215e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,24758,53,0.67 [0.38-1.17],0.1567102321556618
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",24443,52,1.31 [0.93-1.85],0.1270528852407878
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,24603,54,0.83 [0.63-1.08],0.1697595806197407
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,24498,52,1.14 [0.52-2.50],0.7380980538316135
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,24711,53,1.63 [1.03-2.60],0.0386253876579863
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,24498,52,2.59 [1.84-3.64],4.8577107919667296e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,24319,54,4.73 [2.25-9.96],4.2575359767829885e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",21201,45,0.97 [0.60-1.56],0.900245281030484
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",20652,46,0.74 [0.35-1.56],0.4233584854029039
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",21201,45,0.71 [0.54-0.95],0.019171585901672
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,21201,45,0.59 [0.38-0.93],0.0214478378520712
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,20727,44,0.61 [0.31-1.20],0.1526507240826844
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,23930,51,1.34 [0.73-2.47],0.3429150125368054
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,24516,50,0.83 [0.46-1.49],0.5254956289484928
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,24516,50,0.70 [0.48-1.02],0.0612371304528505
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,21170,45,0.69 [0.42-1.15],0.1531992197163572
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,24706,52,2.36 [1.18-4.70],0.0150300106275502
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,23922,51,0.66 [0.28-1.58],0.3533966799303637
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,21201,45,2.65 [1.26-5.58],0.010282177806932
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,24498,53,0.67 [0.50-0.89],0.0064159060344591
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,24684,53,8.46 [3.86-18.53],9.620750984611954e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,24436,50,0.50 [0.29-0.86],0.012437794629591
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,24422,50,1.04 [0.91-1.19],0.5699628114137921
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,20596,45,0.75 [0.45-1.25],0.2708042094395285
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,20596,45,0.91 [0.56-1.48],0.7057530241867893
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,20673,44,0.86 [0.46-1.61],0.6340549447247242
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,23892,51,0.84 [0.69-1.01],0.0661423095791042
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,21264,46,1.16 [0.76-1.77],0.4876163089846995
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,21201,45,1.10 [0.77-1.57],0.5907130940843986
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,24483,54,1.04 [0.95-1.14],0.3745029502126885
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,20668,42,0.67 [0.38-1.17],0.1550524386866108
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,20603,44,1.31 [0.74-2.34],0.3528681145876033
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",24062,52,0.88 [0.70-1.11],0.281435699741902
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,24388,52,2.86 [0.57-14.25],0.1997487435636545
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,24556,53,3.02 [1.34-6.81],0.0075342056243262
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,20652,46,1.63 [1.05-2.54],0.0311968349799758
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,20652,46,0.58 [0.21-1.63],0.3020630714155223
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",24388,52,1.81 [1.22-2.68],0.0030781428393353
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,20668,42,0.79 [0.52-1.22],0.289370003009734
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,21264,46,0.40 [0.18-0.88],0.0226038339495252
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,24076,51,4.94 [2.82-8.67],2.4758161545256824e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,24603,54,0.62 [0.42-0.91],0.0147102750206624
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,21251,46,1.75 [0.85-3.62],0.1319767681199641
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,21115,46,0.71 [0.51-0.97],0.0341442315365204
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,24742,52,0.89 [0.53-1.49],0.6503050828554646
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,24487,51,0.84 [0.65-1.08],0.168793489851856
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,20857,43,1.45 [1.08-1.95],0.0137967763250654
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",21251,46,0.72 [0.43-1.18],0.1933443429464496
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,20652,46,1.91 [1.04-3.51],0.0371413612103567
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,23922,51,0.75 [0.32-1.79],0.5211961370086824
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,20652,46,0.52 [0.25-1.09],0.0814870284239697
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,21259,46,0.52 [0.30-0.90],0.0195891693049673
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,24388,52,1.24 [0.83-1.86],0.2889190902293967
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,21142,45,0.62 [0.43-0.90],0.0111704054073332
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,24556,53,0.85 [0.66-1.10],0.2291531619759571
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,20857,43,1.16 [0.82-1.64],0.4052364797207975
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,21225,45,0.79 [0.55-1.15],0.2237310772888812
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,21225,45,1.54 [0.83-2.84],0.1691675002584065
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,24516,50,0.73 [0.53-1.00],0.0519061177785972
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,24807,53,0.82 [0.63-1.06],0.1273947682298943
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,21166,45,0.82 [0.64-1.05],0.1215751867822909
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,24350,51,0.97 [0.53-1.77],0.9169633625143152
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,20673,44,1.29 [0.98-1.70],0.0730533893516654
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,24429,52,0.89 [0.70-1.14],0.3572099041367726
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,23922,51,1.36 [1.00-1.86],0.0517025422577673
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,20503,43,0.80 [0.25-2.59],0.7058035983301647
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,21251,46,0.86 [0.43-1.72],0.6708222636886468
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,21142,45,0.80 [0.36-1.74],0.5684831028691508
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,24637,53,2.93 [1.66-5.18],0.0002195351063717
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,23847,51,1.12 [0.86-1.46],0.4072861665237618
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,20922,46,1.27 [0.83-1.95],0.2712076355587214
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",24062,52,0.90 [0.64-1.27],0.5671150539838676
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",24807,53,0.93 [0.66-1.30],0.6555396993666192
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,24728,54,0.99 [0.67-1.48],0.970697744316472
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,24062,52,1.45 [0.73-2.91],0.2894079690408312
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,24483,54,1.02 [0.35-2.98],0.968915505698548
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,21251,46,1.99 [1.24-3.19],0.004510609829627
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,21251,46,1.74 [1.03-2.93],0.0371278807999946
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,24062,52,0.86 [0.54-1.37],0.5142508980363482
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,20673,44,1.26 [0.53-3.01],0.599822609587453
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,24516,50,0.83 [0.62-1.12],0.2218279990616798
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,21161,45,0.83 [0.59-1.17],0.2879900777666355
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,24062,52,1.04 [0.59-1.82],0.8972314195939037
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,20596,45,1.46 [0.98-2.19],0.0643710546328173
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,20778,43,0.80 [0.63-1.00],0.0474603806043249
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,23922,51,0.97 [0.67-1.40],0.8540417152937286
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,24742,52,1.05 [0.77-1.44],0.7390390151506994
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,21201,45,2.59 [1.71-3.92],7.288026333086198e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,24534,51,0.57 [0.34-0.94],0.0278793073773093
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,20596,45,1.11 [0.52-2.35],0.7911848891651693
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,24498,53,0.63 [0.40-1.00],0.0496920077090935
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,21284,46,0.65 [0.36-1.19],0.164521600974122
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,20640,43,0.91 [0.60-1.39],0.659165472043469
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,20652,46,0.58 [0.28-1.20],0.1430146171294508
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,20668,42,2.90 [1.49-5.62],0.0016572775251735
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,24563,51,1.18 [0.77-1.83],0.442796278256402
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,20652,46,2.17 [1.48-3.19],7.44756411963364e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,24426,50,1.30 [0.71-2.38],0.3972700719118026
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,21201,45,1.79 [0.94-3.41],0.0789343156094691
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,24393,54,2.29 [1.35-3.90],0.0021292455043233
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,23930,51,0.80 [0.65-0.99],0.0382014381533202
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,24728,54,3.72 [2.39-5.79],6.6369534432803745e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,23877,50,1.00 [0.59-1.69],0.9896915076332634
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,20857,43,1.70 [0.81-3.58],0.1623377327679953
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,21059,45,2.02 [0.97-4.23],0.060809341146349
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,21166,45,0.67 [0.38-1.17],0.1603018608735991
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,21166,45,1.06 [0.94-1.19],0.3430267620257171
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,24350,51,0.94 [0.76-1.16],0.5662887536231378
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,24498,53,0.96 [0.65-1.41],0.8331353288330525
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,23922,51,1.09 [0.65-1.82],0.7417938890712119
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,20503,43,0.87 [0.32-2.34],0.7824282609359795
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,21225,45,1.19 [0.69-2.05],0.5227668397492641
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,20673,44,1.16 [0.73-1.83],0.5293261944081742
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,24388,52,1.16 [0.76-1.75],0.4883125953182284
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,24323,51,1.12 [0.58-2.17],0.7351616321134371
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,24238,51,1.58 [0.81-3.06],0.1784272299875742
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,24498,53,1.31 [0.82-2.08],0.2532092506529626
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,20652,46,1.29 [0.82-2.03],0.2652054906966414
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,24498,53,0.93 [0.73-1.20],0.5966712320212656
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,23922,51,0.90 [0.58-1.38],0.6256486256130911
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,20004,39,0.76 [0.59-0.98],0.0354911155107226
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",23930,51,0.72 [0.31-1.63],0.4277084038172474
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,24294,50,2.59 [1.40-4.79],0.0023621613822014
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,20497,46,0.67 [0.39-1.14],0.1351328620862317
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,21259,46,1.20 [0.87-1.66],0.2659458536722833
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,20673,44,1.17 [0.83-1.65],0.367198167645087
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,24498,53,1.18 [0.67-2.08],0.5707165850790387
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,23930,51,2.22 [1.26-3.91],0.0057631666389466
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,24076,51,2.05 [1.51-2.76],3.0145557063304186e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,20652,46,1.70 [1.17-2.46],0.0053897692810588
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,24350,51,0.78 [0.56-1.09],0.1454191400832768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,24568,54,0.78 [0.62-0.99],0.0440853972228947
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,20609,46,0.78 [0.35-1.74],0.5383764557669388
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,21259,46,1.47 [0.60-3.59],0.3989324269053698
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,21251,46,2.95 [1.01-8.56],0.0471453916586237
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,24801,53,0.99 [0.43-2.28],0.9791384906862488
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,21166,45,2.73 [2.04-3.65],1.1426113346825648e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,21166,45,2.64 [1.36-5.15],0.0042775788565462
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,24452,53,6.42 [2.75-14.96],1.665054223225578e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,24260,51,2.26 [1.09-4.67],0.0279305093620557
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,21201,45,0.44 [0.21-0.94],0.0329126612227388
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,24801,53,1.17 [0.45-3.08],0.746992645361755
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,21259,46,4.25 [2.35-7.70],1.8558424957738272e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,20778,43,0.65 [0.40-1.06],0.0879104240319017
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,23822,51,2.46 [1.90-3.20],1.3115484149850224e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,20857,43,0.73 [0.34-1.56],0.4185170287234923
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,24498,53,2.26 [1.24-4.11],0.0074954409688624
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,24634,54,0.92 [0.75-1.13],0.4203998891530797
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,24742,52,2.69 [1.64-4.41],9.0581832346641e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,21142,45,1.34 [0.97-1.84],0.074505656011839
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,23930,51,0.93 [0.57-1.51],0.7604062501307148
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,20668,42,0.31 [0.13-0.74],0.0087766535364248
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,20596,45,1.37 [1.04-1.80],0.0257965777731594
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,21284,46,1.09 [0.64-1.85],0.7575571260507405
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,24398,50,0.88 [0.49-1.58],0.6669317169398961
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,24502,53,1.90 [0.77-4.69],0.1657730419743734
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,20843,46,1.30 [0.84-2.02],0.2349675915819985
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,21259,46,0.44 [0.25-0.79],0.0055544705266813
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,21259,46,0.77 [0.60-0.99],0.0386495470550928
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,21259,46,0.63 [0.47-0.84],0.0020997275272574
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,21142,45,0.62 [0.38-1.00],0.0476459169736359
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,20596,45,0.69 [0.44-1.09],0.1105364394448005
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,24062,52,0.76 [0.54-1.09],0.1374287112795039
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,20596,45,0.72 [0.44-1.15],0.1697565854852791
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,20603,44,1.40 [1.05-1.86],0.0214264745517587
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,21142,45,1.07 [0.64-1.79],0.8045440542707017
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,24498,53,1.21 [0.74-1.99],0.4452366446635579
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,23930,51,0.80 [0.45-1.43],0.4531930850192593
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,20778,43,0.71 [0.48-1.05],0.0831171179783998
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,23922,51,1.11 [0.76-1.63],0.5921976487132508
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,24062,52,1.08 [0.72-1.61],0.7050159688588497
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,20673,44,0.93 [0.59-1.46],0.7464778556158238
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,23922,51,0.95 [0.55-1.62],0.8445410082295843
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,20857,43,1.22 [0.80-1.86],0.3586167723309277
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,20652,46,0.44 [0.17-1.16],0.0981446436662735
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,21142,45,1.37 [0.91-2.04],0.1277590441754382
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,20668,42,0.70 [0.39-1.24],0.2218872644721906
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,20603,44,0.53 [0.21-1.33],0.1764662599037048
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,23922,51,0.53 [0.28-1.01],0.0551468943512987
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,20652,46,0.81 [0.49-1.34],0.4181756542123352
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,20857,43,0.71 [0.39-1.29],0.2571223697873878
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,23922,51,0.97 [0.46-2.06],0.9449503718894106
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,24616,51,0.65 [0.38-1.12],0.118614212353834
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,23930,51,1.06 [0.51-2.23],0.8738209049962071
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,20503,43,1.79 [1.05-3.03],0.0310033841969356
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,23922,51,0.96 [0.63-1.48],0.8643889166927443
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,21225,45,1.84 [1.20-2.82],0.0048477721503548
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,23952,51,1.78 [1.14-2.77],0.0109549328205413
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,21225,45,0.75 [0.51-1.10],0.1431119122695231
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,20596,45,1.45 [0.94-2.23],0.0908169705170137
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,20503,43,0.77 [0.39-1.51],0.4412281325239401
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,20673,44,0.84 [0.51-1.38],0.4802328976426269
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,24388,52,1.46 [1.08-1.96],0.0129339315863779
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,24388,52,1.48 [1.02-2.15],0.0392304725544053
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,21166,45,1.32 [0.91-1.92],0.1476545623356535
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,20652,46,1.40 [1.07-1.84],0.0154528922826344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,20668,42,0.81 [0.60-1.09],0.1642657202842578
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,21142,45,1.15 [0.72-1.84],0.5463328283538735
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,24076,51,0.85 [0.44-1.65],0.6242768767240277
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,20668,42,2.85 [0.75-10.88],0.1258780663987598
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,21225,45,0.66 [0.39-1.12],0.1246572072367204
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,24346,51,1.30 [0.81-2.08],0.2710079995463639
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,24801,53,1.20 [0.80-1.78],0.3765526801867199
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,24801,53,1.27 [0.87-1.85],0.214252417608395
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,21142,45,0.51 [0.24-1.09],0.0840176197511324
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,24527,54,1.57 [0.99-2.49],0.0563116156749318
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,20652,46,0.91 [0.49-1.68],0.7647371194426328
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,24498,52,2.07 [0.90-4.76],0.0855936680611813
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REN,Renin,24516,50,1.41 [1.06-1.88],0.0174791225722774
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,20652,46,1.04 [0.51-2.12],0.922090027965904
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,20503,43,0.70 [0.28-1.74],0.4459581562536714
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,24388,52,1.44 [0.77-2.68],0.2529015835422181
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RETN,Resistin,24427,52,1.23 [0.70-2.17],0.4679324641178314
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",20596,45,1.40 [0.92-2.14],0.115004084845843
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,21142,45,0.54 [0.13-2.22],0.3917148806026841
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,21225,45,0.65 [0.45-0.94],0.020707210769917
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,20857,43,0.73 [0.42-1.30],0.2864655388352691
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,24742,52,1.05 [0.48-2.28],0.909079155932661
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,24742,52,1.62 [0.65-4.06],0.3025303009868391
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,21225,45,0.68 [0.41-1.12],0.1285727963246419
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,24062,52,1.09 [0.77-1.55],0.6249680517262234
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,24199,51,0.76 [0.63-0.93],0.0060596138495177
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,20652,46,1.31 [0.83-2.08],0.243678660998446
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,20778,43,1.43 [0.85-2.38],0.1755898216036827
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,24665,54,1.11 [0.75-1.65],0.585891554250907
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,21259,46,0.72 [0.55-0.94],0.0156008972670886
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,20596,45,1.53 [1.19-1.98],0.0010516670690696
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,21225,45,0.92 [0.57-1.49],0.739186162316307
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,20746,43,1.07 [0.84-1.37],0.5997847105967584
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,21264,46,0.92 [0.27-3.07],0.8902994079788658
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,20668,42,1.04 [0.56-1.93],0.8985953761927405
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,24391,50,1.09 [0.89-1.34],0.3986380740591463
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,20575,43,0.47 [0.15-1.51],0.2060214790227611
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,21109,45,1.79 [0.97-3.32],0.0618826153648196
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,21225,45,0.44 [0.20-0.98],0.0454127039000584
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,24681,53,2.62 [1.29-5.33],0.0078062273887275
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,20668,42,2.16 [0.87-5.38],0.0989855262187484
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,20652,46,0.61 [0.26-1.40],0.2404039210659326
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,20652,46,0.74 [0.47-1.14],0.1726005176963748
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,20857,43,0.98 [0.62-1.53],0.9234205823768792
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,23922,51,0.93 [0.64-1.35],0.7026623740257116
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,20857,43,1.20 [0.80-1.80],0.3721098119191672
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,20668,42,0.60 [0.41-0.86],0.0061509720625456
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,24527,54,9.15 [4.95-16.90],1.536271059685146e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,24742,52,8.91 [3.76-21.14],6.847110404546753e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,20668,42,13.59 [2.88-64.10],0.0009794646569342
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,24516,50,3.48 [1.62-7.46],0.0014029404554538
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,24388,52,0.74 [0.40-1.34],0.3153024730579795
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,20652,46,0.65 [0.24-1.77],0.3946754826307471
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,20857,43,0.79 [0.51-1.24],0.3081251863617079
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,20673,44,0.70 [0.31-1.58],0.3940110828109595
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,20668,42,1.29 [0.70-2.38],0.4091082420420092
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,20596,45,1.23 [0.70-2.17],0.467665592339344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,20673,44,0.79 [0.63-1.01],0.0585290630739375
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,23922,51,1.16 [0.76-1.78],0.4828511040517408
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,23922,51,1.04 [0.73-1.50],0.8187265676311681
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,20603,44,1.11 [0.82-1.50],0.505486265042142
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,24350,51,1.21 [0.61-2.41],0.5805366784893404
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,24728,54,0.53 [0.21-1.33],0.1744425761332975
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,24388,52,3.19 [1.67-6.08],0.0004367990211742
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,20596,45,0.83 [0.44-1.55],0.5513457725580468
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",21225,45,0.75 [0.55-1.02],0.0682118913579017
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,24728,54,1.54 [0.88-2.68],0.1273849292894837
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,23922,51,0.89 [0.68-1.17],0.4020091218637831
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,24742,52,0.70 [0.48-1.03],0.074287682070367
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,20596,45,2.06 [1.33-3.18],0.0011174089878341
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,24316,50,1.10 [0.68-1.77],0.7041792287124566
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,24156,52,1.16 [0.84-1.61],0.3559481383390114
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,20652,46,0.92 [0.40-2.09],0.8359751297751546
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,21225,45,1.30 [0.79-2.14],0.2982017936992151
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,23893,51,1.00 [0.67-1.50],0.9904597469808912
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,21142,45,1.29 [0.81-2.04],0.2832641288799246
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,24556,53,0.79 [0.52-1.19],0.2598874585402707
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,21225,45,1.60 [0.94-2.71],0.0819725118903683
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,24076,51,1.49 [1.09-2.05],0.0135957883234303
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,21284,46,0.79 [0.47-1.30],0.3520955442253837
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,21225,45,0.55 [0.17-1.74],0.3098725339858363
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,20603,44,0.89 [0.50-1.60],0.695899010786385
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,24498,53,0.96 [0.69-1.33],0.7961640698107108
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,20857,43,1.49 [1.20-1.85],0.0003355711326881
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,21192,46,0.76 [0.59-0.97],0.0264494247323667
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,20596,45,1.32 [0.77-2.25],0.3112858628488363
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,20596,45,1.39 [0.90-2.14],0.1334043550090357
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,20857,43,0.93 [0.60-1.44],0.7493068832920102
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,21225,45,0.58 [0.19-1.81],0.3468117766657306
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,21213,46,0.97 [0.43-2.16],0.9339952692985268
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,24388,52,0.88 [0.65-1.18],0.3895526020278531
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,24742,52,0.97 [0.42-2.24],0.9471555191811672
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,23930,51,1.28 [0.92-1.78],0.1490038279683295
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,23883,51,2.98 [1.65-5.40],0.0003152328360716
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,24801,53,0.98 [0.56-1.72],0.9390325080401618
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,24742,52,6.08 [2.89-12.80],1.951535992792185e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,24630,54,1.51 [0.72-3.17],0.279421596361019
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,24527,54,3.75 [1.86-7.55],0.0002218280411132
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,24535,53,0.79 [0.53-1.18],0.2473244793986099
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,20596,45,1.19 [0.51-2.74],0.6910666051016802
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,20778,43,0.89 [0.27-2.88],0.8449719434617176
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,24568,54,0.93 [0.69-1.25],0.6257139606462578
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,24062,52,1.74 [1.05-2.87],0.0306433946053282
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,20603,44,1.22 [0.87-1.70],0.2425018021200699
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,24665,54,1.69 [1.09-2.62],0.0181542166372856
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,20603,44,1.08 [0.62-1.90],0.7831642087688333
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,20673,44,1.06 [0.39-2.91],0.9078918168655902
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,20673,44,1.28 [0.71-2.30],0.4147943714167695
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,20603,44,1.42 [0.87-2.33],0.1593988474275081
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,20668,42,1.57 [0.80-3.08],0.1929783802932372
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,23922,51,1.26 [0.98-1.63],0.0747453151890137
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,20597,42,1.01 [0.56-1.80],0.9825976301645332
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,21259,46,0.47 [0.16-1.41],0.1787927753245786
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,20668,42,1.06 [0.79-1.44],0.6922192349278176
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,24498,53,0.95 [0.61-1.47],0.805511373946438
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCT,Secretin,20673,44,0.68 [0.35-1.34],0.2665421009260297
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,24516,50,2.54 [1.74-3.70],1.1719417322549871e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,24516,50,0.39 [0.24-0.63],0.0001490110507093
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,21142,45,0.86 [0.67-1.10],0.2331263580897519
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,21166,45,1.42 [1.05-1.93],0.022705103333284
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,20778,43,2.45 [1.35-4.45],0.0033359120008547
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,20668,42,0.71 [0.49-1.03],0.0702269299334523
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,20668,42,1.49 [0.86-2.61],0.1571601778876244
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,24801,53,2.27 [1.40-3.68],0.0009120387683313
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,21284,46,0.69 [0.35-1.37],0.2868997421778727
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,21284,46,0.85 [0.24-2.96],0.7979083976680118
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,24563,51,0.89 [0.58-1.37],0.5908331221444755
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,24498,53,1.04 [0.45-2.42],0.9277722380141884
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,24516,50,2.16 [0.86-5.43],0.1032059240661183
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,20778,43,1.58 [0.88-2.87],0.1282081277277202
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,24388,52,1.90 [1.21-2.98],0.0054536817157714
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,24742,52,0.80 [0.36-1.78],0.580635756661293
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,20652,46,1.10 [0.40-2.98],0.8579661058297074
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,24711,53,7.74 [4.85-12.33],7.797964380181759e-18
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,21225,45,1.23 [0.89-1.70],0.2204523864113974
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,20857,43,0.47 [0.21-1.07],0.0724341436169221
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,21153,45,1.98 [0.99-3.94],0.0529055655160582
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,24388,52,1.13 [0.50-2.53],0.7721170321129807
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,20899,46,0.77 [0.02-26.73],0.8860938978718371
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,24801,53,3.01 [1.64-5.53],0.0003632740813784
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,23843,48,1.18 [1.00-1.39],0.0462163120648354
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,21219,46,0.74 [0.26-2.10],0.5675743462568378
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,20897,45,0.64 [0.34-1.23],0.1797806023466563
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,20973,46,0.68 [0.42-1.09],0.1116594319569953
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,21284,46,0.69 [0.13-3.81],0.6746659724991937
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,21284,46,3.20 [0.78-13.12],0.1065406496074071
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,24266,52,1.77 [1.32-2.38],0.0001517641809793
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,24421,51,0.80 [0.60-1.06],0.1177786215968542
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,24076,51,1.58 [0.94-2.66],0.0866067719970992
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,24665,52,0.74 [0.49-1.13],0.1622289327919592
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,24807,53,1.36 [1.02-1.81],0.0348998551352214
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,24350,51,0.48 [0.24-0.96],0.0379746825934951
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,21242,46,0.37 [0.17-0.81],0.0133313140036676
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,21242,46,0.55 [0.33-0.91],0.0194408608969011
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,24801,53,0.82 [0.58-1.16],0.2584450378648005
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,21259,46,0.62 [0.39-0.96],0.033192595288515
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,20977,46,0.34 [0.12-1.01],0.0516769857839472
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,20892,46,0.31 [0.10-0.95],0.0407689723818401
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,21242,46,0.61 [0.27-1.34],0.2160825132506955
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,20857,43,0.87 [0.69-1.09],0.2189672384516309
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,20731,42,1.82 [0.78-4.26],0.1651296627984994
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,21166,45,1.12 [0.70-1.78],0.6427051021191055
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,23930,51,0.86 [0.58-1.29],0.4735532421891099
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,24273,51,1.03 [0.45-2.34],0.9489613044812284
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,20673,44,1.71 [0.80-3.65],0.164163494122581
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,24556,53,5.13 [2.37-11.12],3.4532734713653896e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,24388,52,5.68 [3.16-10.22],6.603150542923117e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,24388,52,1.21 [0.89-1.65],0.2279604563567288
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,24266,51,1.25 [0.74-2.09],0.4068719246204371
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,20778,43,0.99 [0.49-2.01],0.97926641581907
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,23922,51,0.94 [0.59-1.48],0.7748081328051385
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,23922,51,0.93 [0.58-1.50],0.7734001337824363
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,24516,50,1.30 [0.89-1.89],0.1744547622522398
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,20921,45,1.25 [0.79-1.98],0.3474256513399444
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,23922,51,0.87 [0.68-1.11],0.2575923319017554
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,24498,53,1.01 [0.67-1.53],0.9639999612292734
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,20603,44,0.90 [0.54-1.52],0.702353471102249
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,21166,45,0.66 [0.33-1.32],0.2430103730865778
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,20729,43,1.05 [0.74-1.49],0.7787473169520666
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,21201,45,0.90 [0.59-1.38],0.631532213392283
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,21264,46,2.59 [1.51-4.46],0.0005780542462369
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,20503,43,1.23 [0.99-1.53],0.0584654335021303
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,20561,45,1.31 [1.05-1.62],0.0156888930481129
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,20652,46,1.26 [0.70-2.25],0.4372600398068466
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,21251,46,2.62 [1.36-5.07],0.0041073222675526
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",24568,54,0.91 [0.69-1.20],0.5224936841098182
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,20857,43,1.12 [0.58-2.17],0.7424599577379232
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,24513,53,1.21 [0.73-2.00],0.4576747320815586
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,24603,54,3.13 [2.12-4.64],1.2058214644957606e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,24498,53,5.36 [3.06-9.39],4.278939195004971e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,23930,51,1.02 [0.75-1.38],0.9151302829606304
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,24498,52,1.27 [0.97-1.66],0.0806778226870281
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,24728,54,2.45 [1.32-4.56],0.0046085482856417
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,24516,50,5.29 [2.80-9.96],2.6227562194246925e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,20668,42,2.89 [1.59-5.26],0.0005234414388759
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,24697,54,3.02 [1.38-6.59],0.0055831808689876
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,20668,42,1.72 [1.01-2.92],0.0452912066538287
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,24547,52,1.41 [0.88-2.25],0.1571320949182131
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,24432,54,2.29 [1.38-3.83],0.0014426214467503
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,20652,46,0.61 [0.34-1.08],0.0898092439708834
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,24388,52,0.80 [0.61-1.06],0.1193239349393546
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",23930,51,1.09 [0.71-1.65],0.7002534158293241
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,24062,52,0.89 [0.57-1.39],0.61365620843097
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,24303,51,0.79 [0.56-1.11],0.1700855206797271
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,24603,54,0.77 [0.61-0.97],0.023407530180942
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,20596,45,0.94 [0.47-1.90],0.8646226588018001
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,21225,45,0.71 [0.55-0.93],0.0121497043095676
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,24062,52,2.34 [1.65-3.33],2.1555802759437627e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,23922,51,1.07 [0.55-2.06],0.8494884514956418
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,24498,53,1.83 [1.25-2.67],0.001860444972618
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,23922,51,2.67 [1.71-4.15],1.3873089806173314e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,20596,45,1.41 [0.73-2.71],0.3006967665469284
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,21142,45,0.85 [0.48-1.48],0.5607507451689844
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,23930,51,1.14 [0.78-1.66],0.5134860171301829
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,20673,44,0.86 [0.47-1.58],0.6311166284658511
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,23930,51,1.00 [0.68-1.46],0.9963847256119052
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,20503,43,0.71 [0.38-1.31],0.2734952418836841
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,20503,43,1.47 [0.97-2.25],0.0719447788339573
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,23930,51,1.09 [0.52-2.26],0.8188083735038396
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,24498,53,1.38 [0.99-1.92],0.0547364869915653
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,20673,44,1.06 [0.72-1.57],0.7524147123837347
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,21251,46,1.91 [1.11-3.27],0.0192772353374475
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,20596,45,1.36 [1.02-1.82],0.0380478995288201
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,20778,43,0.68 [0.47-0.96],0.0299078131760127
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,21166,45,1.17 [0.76-1.79],0.485083827505542
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",20503,43,0.49 [0.24-0.99],0.0481804813226645
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,23930,51,1.74 [1.32-2.29],0.000100845778022
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,20652,46,1.13 [0.48-2.69],0.7739801361129948
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,24728,54,1.38 [0.75-2.56],0.2992087881694127
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,24076,51,1.58 [0.82-3.05],0.1746400297222106
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,20857,43,1.08 [0.78-1.51],0.6359725187689669
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,21166,45,0.73 [0.51-1.05],0.0857294627960515
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,21101,46,0.77 [0.33-1.80],0.5496955266927137
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,23922,51,0.80 [0.59-1.08],0.1497147877173196
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,21142,45,0.61 [0.39-0.95],0.0279100774635114
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,21142,45,0.78 [0.44-1.40],0.411025481700317
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,24388,52,0.63 [0.20-2.01],0.4320837726825993
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,23930,51,0.72 [0.49-1.06],0.094962222015472
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,20503,43,1.14 [0.71-1.82],0.5915438481093168
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,21166,45,0.99 [0.64-1.54],0.9727826697770422
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,24728,54,2.27 [1.19-4.32],0.0124644419081264
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,24603,54,1.42 [0.77-2.63],0.2582118741029304
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,24623,52,2.45 [1.64-3.64],1.0167489479932184e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,20652,46,0.98 [0.59-1.62],0.9422326374355896
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,24552,54,1.19 [0.81-1.75],0.3652586007370028
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,21142,45,0.87 [0.56-1.35],0.5451864179502053
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,20603,44,0.81 [0.49-1.36],0.4307692383322729
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,21154,45,0.85 [0.62-1.18],0.3367848606593717
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,24516,50,0.69 [0.53-0.89],0.0046034436962999
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,20603,44,0.70 [0.37-1.30],0.254589816911542
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,24556,53,0.77 [0.60-1.00],0.0466834194763112
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,21225,45,0.86 [0.52-1.42],0.5615930644013123
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,20778,43,0.84 [0.66-1.08],0.1825376415643242
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,24350,51,1.20 [0.82-1.76],0.3550225995178523
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",20668,42,2.04 [1.00-4.15],0.0490706393438501
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',21201,45,1.12 [0.68-1.83],0.6611645849340022
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,20596,45,1.20 [0.83-1.73],0.3344125919458589
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,20778,43,0.80 [0.46-1.37],0.4104870290778634
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,21166,45,0.56 [0.26-1.23],0.1504083109155157
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,21142,45,0.69 [0.46-1.03],0.0719754884523531
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,20668,42,0.49 [0.16-1.50],0.2130037449905184
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,24516,50,0.88 [0.61-1.28],0.5159953336867614
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],23966,49,0.95 [0.56-1.61],0.8473536297809067
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",24498,52,1.40 [0.79-2.47],0.2520379679195654
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,21264,46,0.99 [0.63-1.57],0.9701904039545844
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,21225,45,0.83 [0.36-1.89],0.6590883759376869
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,23922,51,1.39 [0.67-2.86],0.3727674210062836
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,24619,54,1.04 [0.74-1.46],0.8144566892932661
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,24488,50,1.13 [0.59-2.16],0.7200989149507296
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,24488,50,0.93 [0.49-1.76],0.8200639003717385
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,20673,44,0.59 [0.27-1.31],0.1953158723003256
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,21189,45,1.76 [0.58-5.36],0.3213068492503942
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,20673,44,1.80 [0.62-5.17],0.277564508994978
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,21225,45,1.76 [0.98-3.16],0.0596482898305759
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,21225,45,0.98 [0.60-1.59],0.9299837676367096
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,24556,53,0.85 [0.62-1.17],0.3236382413493927
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,24482,51,0.99 [0.40-2.45],0.9834387210600308
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPART,Spartin,20778,43,0.80 [0.54-1.17],0.2531747609090103
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,21259,46,1.80 [0.77-4.23],0.1751999360626503
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,24498,52,1.67 [1.00-2.77],0.0489054603403573
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,20778,43,0.63 [0.28-1.40],0.2593503261193051
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,24498,53,1.24 [0.86-1.79],0.2406906133125097
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,24498,52,1.96 [0.98-3.89],0.0555100878767721
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,24728,54,0.91 [0.59-1.42],0.6911689038765363
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,20596,45,0.70 [0.27-1.77],0.4474282153313026
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,24410,51,5.90 [3.97-8.77],1.4453181088763665e-18
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,24603,54,1.21 [0.67-2.17],0.5257374210036208
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,21166,45,0.91 [0.76-1.08],0.26979700099387
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,24350,51,2.93 [1.21-7.11],0.017685848861172
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,24527,54,3.85 [2.59-5.70],2.087480078922601e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,24402,50,5.83 [3.22-10.56],5.8453269964970675e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,24753,52,3.51 [2.31-5.31],3.229252592959779e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",20652,46,0.78 [0.38-1.59],0.4901091761826955
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,20503,43,0.44 [0.20-0.98],0.0455166772659816
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,20857,43,0.94 [0.65-1.36],0.7549788942110855
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,21201,45,0.89 [0.58-1.37],0.5919764066998399
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,24062,52,0.74 [0.56-0.99],0.0389013488349509
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",20603,44,0.95 [0.38-2.35],0.9079303312693726
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,21201,45,1.23 [0.64-2.37],0.5399292229513142
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,24516,53,0.87 [0.72-1.06],0.1621284468338477
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,24388,52,1.22 [0.84-1.77],0.2965669352420904
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,24498,53,0.87 [0.64-1.18],0.3717575751790684
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,21259,46,5.57 [3.04-10.20],2.792010559571189e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,23930,51,0.96 [0.62-1.49],0.8534932741387964
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",20652,46,0.70 [0.28-1.72],0.4377297256096288
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,24488,50,0.68 [0.54-0.85],0.0007231207701068
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,24563,51,1.32 [0.74-2.33],0.3467510695544707
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,20503,43,0.97 [0.36-2.65],0.9538859679670224
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,21166,45,1.21 [0.72-2.05],0.4699051667283611
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,20778,43,0.65 [0.38-1.10],0.1061677515978012
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",24388,52,0.70 [0.37-1.33],0.279212130958408
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",24801,53,1.91 [0.87-4.19],0.1093313404483348
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",20652,46,0.88 [0.45-1.73],0.7125769392213821
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,21251,46,1.46 [0.55-3.85],0.4475468915316839
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,21142,45,0.59 [0.24-1.44],0.2486845852002081
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,24303,51,0.79 [0.53-1.17],0.2369342166711737
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,20652,46,0.61 [0.41-0.91],0.0143700073408086
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,24388,52,0.87 [0.73-1.04],0.1241400917037587
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,20503,43,0.85 [0.52-1.39],0.5232023265625345
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,24742,52,1.86 [1.14-3.03],0.0122624890704027
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,24460,52,0.69 [0.28-1.74],0.4350570771242219
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,20603,44,0.92 [0.60-1.40],0.6833256826065217
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,24454,51,0.81 [0.55-1.20],0.292712895857714
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,24076,51,0.87 [0.62-1.22],0.4182640969139976
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,23930,51,0.82 [0.54-1.23],0.3274288522917163
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,24516,50,0.71 [0.53-0.95],0.0221318278820071
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",20503,43,0.76 [0.53-1.09],0.1347465533702744
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,23922,51,0.97 [0.62-1.52],0.8974567447033635
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,20673,44,0.79 [0.54-1.16],0.2327539391284035
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,21201,45,0.61 [0.23-1.58],0.3052655888267205
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,24388,52,1.15 [0.80-1.67],0.4464250933315423
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,20652,46,0.82 [0.37-1.80],0.6174201656637914
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,23922,51,0.86 [0.57-1.30],0.4781578535122427
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,20652,46,0.72 [0.40-1.30],0.2785001114772242
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,24498,53,0.86 [0.51-1.44],0.5635929279746106
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,21225,45,0.72 [0.51-1.02],0.0655437344444833
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,23922,51,1.09 [0.63-1.87],0.7660563208347186
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,21166,45,0.56 [0.26-1.25],0.1561744905361249
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,23922,51,0.95 [0.70-1.29],0.7338134479597864
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,24742,52,0.82 [0.68-0.98],0.0263965566800031
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,24498,53,1.83 [1.42-2.37],3.534206136592867e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,20652,46,0.89 [0.56-1.42],0.6208816623818356
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,24742,52,0.83 [0.53-1.28],0.3888529633857753
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",21225,45,1.48 [1.02-2.15],0.0369659418407877
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,24076,51,0.48 [0.30-0.78],0.0028870802020402
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,24498,52,2.21 [1.22-4.00],0.009001045299338
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,21142,45,2.08 [1.36-3.19],0.0007644508952789
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,20668,43,1.18 [0.50-2.77],0.700794532235733
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,20673,44,1.28 [0.86-1.90],0.2250504848467921
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,21166,45,1.43 [0.74-2.78],0.2888337102848326
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,20778,43,0.67 [0.39-1.17],0.1576647075230141
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,20603,44,0.47 [0.23-0.95],0.0347034810348537
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,21201,45,0.75 [0.31-1.82],0.5310925139979124
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,21259,46,0.57 [0.37-0.88],0.0123120918967358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,20857,43,0.79 [0.59-1.04],0.0908615960940818
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,24388,52,0.79 [0.65-0.97],0.0243075157541903
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,21742,48,6.44 [3.07-13.51],8.53474603066868e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,21142,45,0.59 [0.28-1.22],0.1530365313599954
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,24388,52,1.27 [0.63-2.56],0.5055830815989671
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,20503,43,1.17 [0.76-1.79],0.4748557745845267
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,21181,46,0.80 [0.42-1.50],0.4805227800041863
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,24062,52,0.67 [0.46-0.97],0.0322367828598654
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,20857,43,0.93 [0.54-1.59],0.7885960487664858
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,23930,51,0.84 [0.61-1.15],0.2732974266293897
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",20673,44,1.08 [0.76-1.53],0.6747361092195272
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",21142,45,0.73 [0.33-1.61],0.4315923680418889
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,21201,45,0.75 [0.46-1.22],0.2465777816553714
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,23930,51,1.30 [0.80-2.12],0.2833182249082717
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,24388,52,0.81 [0.62-1.08],0.1481194502097452
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,24498,53,1.06 [0.79-1.44],0.6803135285568032
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,20778,43,0.80 [0.56-1.13],0.1961385201261444
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,24350,51,0.77 [0.61-0.97],0.0257301239219007
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,24350,51,0.70 [0.52-0.95],0.0227866925517285
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,23922,51,0.92 [0.69-1.23],0.5784147928436483
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,20673,44,0.39 [0.15-1.04],0.0590160072075314
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,24305,51,1.00 [0.78-1.30],0.9710046569431282
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,24076,51,0.97 [0.70-1.35],0.8552696498329078
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,20841,45,1.38 [0.68-2.77],0.3721617174815144
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,24753,52,1.27 [0.57-2.83],0.5566688889158438
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,21259,46,1.80 [0.96-3.39],0.0674856457986854
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,20857,43,1.33 [0.97-1.83],0.0768340090411134
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,21259,46,1.87 [0.74-4.72],0.1824109736866378
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,23930,51,1.01 [0.85-1.20],0.9083754205422768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",20673,44,1.24 [0.68-2.25],0.4853844402070455
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,21142,45,0.73 [0.44-1.21],0.2273121256716821
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,23930,51,0.93 [0.68-1.26],0.6255388638477175
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,20596,45,1.12 [0.58-2.16],0.7417041342238456
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,24556,53,4.86 [1.80-13.18],0.0018669475895747
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,20652,46,1.02 [0.39-2.67],0.9630927116570664
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,20828,43,0.97 [0.71-1.32],0.826766938143908
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,20673,44,0.97 [0.54-1.73],0.9070460306593549
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,20857,43,0.62 [0.24-1.62],0.3293523383258568
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,21284,46,0.40 [0.11-1.44],0.1619990778865159
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,20603,44,0.66 [0.37-1.18],0.1599954088516339
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,24386,51,1.23 [0.92-1.64],0.1711979855202254
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,24568,54,2.01 [1.43-2.83],5.731425067279611e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,24465,51,1.75 [1.27-2.41],0.00065298569813
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,24403,51,0.47 [0.21-1.06],0.0695575367497182
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,24473,53,1.76 [1.31-2.37],0.0002052795160498
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,24581,50,1.32 [0.71-2.47],0.3849551728067918
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,21142,45,0.90 [0.69-1.18],0.4536036350419823
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,24498,53,1.46 [0.92-2.33],0.1108003142808004
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,24759,53,2.64 [1.57-4.44],0.0002550508031774
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,21142,45,1.35 [0.90-2.03],0.1426401642658546
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,24326,51,5.32 [2.47-11.47],2.039097194923611e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,20652,46,1.09 [0.32-3.69],0.8936363505551859
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,24556,53,2.55 [1.38-4.74],0.0029429582528273
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,24801,53,1.36 [0.61-3.01],0.4532113924538793
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,24473,50,1.05 [0.76-1.47],0.7544790487427366
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,21264,46,1.19 [0.39-3.63],0.7587625463370924
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,20460,43,1.01 [0.73-1.39],0.9518486233092855
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,24516,50,2.28 [0.97-5.34],0.0573814238398519
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,24498,52,4.46 [3.10-6.44],1.0892078423326562e-15
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,24492,51,2.52 [1.52-4.19],0.0003417584352627
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,24417,50,1.49 [0.70-3.18],0.3008477247945537
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,24076,51,0.30 [0.16-0.60],0.0005361641043248
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,20596,45,0.99 [0.77-1.27],0.9319546375391166
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,20502,46,1.93 [1.17-3.19],0.010573499230185
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,21101,45,0.76 [0.55-1.04],0.0892634881126068
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,24742,52,3.49 [1.54-7.89],0.0027042879663341
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,23811,51,0.85 [0.69-1.05],0.1433249170409272
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,24801,53,3.77 [1.65-8.65],0.0016987975816747
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",23883,51,0.93 [0.54-1.58],0.7749287472733324
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,20857,43,1.56 [0.92-2.65],0.0983284190843623
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,24563,51,2.01 [1.18-3.41],0.0098249072143625
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,21259,46,0.39 [0.17-0.87],0.0210384396231598
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,21201,45,0.83 [0.59-1.15],0.2622371739960404
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,24203,51,2.15 [1.06-4.37],0.0335309857056321
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,21259,46,1.57 [0.82-3.00],0.1744493627866171
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,24603,54,0.98 [0.81-1.17],0.7850899151183486
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,24498,52,1.63 [0.94-2.85],0.084686956270385
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,24442,50,5.56 [2.05-15.09],0.0007666144852459
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,24556,53,0.86 [0.65-1.16],0.3302548624791768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,20603,44,1.61 [1.04-2.48],0.0330270668861046
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",20857,43,1.29 [0.76-2.20],0.3494570626384887
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,20652,46,2.15 [0.87-5.32],0.0966004227258405
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,20857,43,1.47 [0.42-5.18],0.548358844938907
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,24807,53,1.35 [0.89-2.04],0.1554712837380582
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,20652,46,1.32 [0.50-3.49],0.574087202902986
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,20673,44,0.63 [0.34-1.16],0.135417160407769
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,20857,43,1.06 [0.65-1.73],0.8078125420513854
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,20596,45,0.69 [0.29-1.62],0.3928426273669854
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,20596,45,1.24 [0.83-1.84],0.2940288435080395
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,21166,45,0.77 [0.59-1.00],0.0499584316033444
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,21142,45,0.59 [0.38-0.90],0.0157353602425598
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,20668,42,1.55 [1.04-2.33],0.0329898826748148
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,21225,45,1.47 [0.91-2.38],0.1126660551600262
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,20503,43,1.05 [0.52-2.15],0.8834872197108826
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,20603,44,1.29 [0.99-1.68],0.0634590415603124
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,21153,45,0.94 [0.44-2.01],0.8687034113701141
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,24388,52,1.04 [0.79-1.37],0.7667564711177532
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,24225,50,1.03 [0.53-1.97],0.937837622176308
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,24498,52,0.85 [0.61-1.18],0.3282973594691988
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,24563,51,1.74 [1.06-2.83],0.0269198126467292
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,24035,51,1.37 [0.86-2.16],0.1833021224254294
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,21166,45,0.80 [0.44-1.46],0.4658473456238036
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,24062,52,1.11 [0.57-2.13],0.7635439278905465
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,20778,43,0.66 [0.40-1.08],0.0967970976153467
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,24350,51,2.57 [1.74-3.80],1.94394065099835e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,24350,51,1.42 [1.11-1.83],0.0055135424898607
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,24534,52,1.66 [0.98-2.81],0.0597799690968453
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,24807,53,2.74 [1.62-4.64],0.0001674184289141
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,24483,54,5.15 [3.06-8.67],6.974776875015933e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,24556,53,1.94 [1.03-3.67],0.0404356717688766
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,24527,54,2.08 [1.00-4.30],0.0490517276864643
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,24062,52,0.76 [0.42-1.40],0.3836025950100884
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,24527,54,2.47 [1.19-5.09],0.0147197722540934
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,20778,43,1.29 [0.61-2.74],0.5067159216988122
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,24728,54,1.44 [0.68-3.08],0.3439471735013818
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,24498,52,3.27 [1.63-6.54],0.0008261939446907
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,24498,52,1.86 [1.38-2.51],4.891555759589218e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,24742,52,6.06 [2.91-12.59],1.4020265944091067e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,24759,53,3.51 [2.06-5.99],4.038149826987928e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,24350,51,1.85 [1.32-2.59],0.0003885731490615
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,24742,52,1.91 [1.20-3.02],0.0059098758240161
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,24350,51,2.06 [1.22-3.47],0.0066432162211514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,24807,53,0.41 [0.17-1.02],0.0562583848681998
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,24498,53,0.60 [0.41-0.89],0.0104998794408027
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,24807,53,0.65 [0.28-1.48],0.3000749239731473
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,24603,54,2.43 [1.04-5.67],0.0407374866258296
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,24751,53,4.73 [2.93-7.64],2.1077024751496791e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,24350,51,0.86 [0.56-1.32],0.4857081155270899
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,21251,46,3.44 [2.08-5.69],1.4852972208961162e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,21201,45,0.82 [0.59-1.14],0.2307914043716716
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,21251,46,0.83 [0.44-1.59],0.5814269148708671
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",24076,51,1.03 [0.76-1.40],0.8658403940758824
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,20857,43,0.71 [0.30-1.67],0.4272979712550121
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,24350,51,1.51 [0.84-2.71],0.1706594156536048
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,24498,52,2.79 [1.16-6.74],0.0225610808618359
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,21259,46,0.64 [0.43-0.95],0.0275561759997348
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,21166,45,1.01 [0.79-1.29],0.9149665229149648
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",20503,43,1.14 [0.66-1.96],0.6312076106170883
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,20652,46,0.72 [0.49-1.05],0.0897461568644719
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,20668,42,0.65 [0.34-1.24],0.1935535531147648
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,23922,51,0.80 [0.44-1.44],0.452227643790749
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,20652,46,1.00 [0.72-1.38],0.9871891098816784
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,20322,41,1.11 [0.64-1.93],0.7171340726351991
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,24076,51,1.05 [0.49-2.25],0.9062067178129106
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,20673,44,0.82 [0.35-1.93],0.6507487806761377
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,20673,44,0.98 [0.47-2.03],0.958134886871568
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,20778,43,0.72 [0.56-0.92],0.0092740040205596
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,21259,46,0.90 [0.33-2.44],0.8333645002686954
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,20596,45,0.94 [0.48-1.83],0.8508541110530659
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,23922,51,1.03 [0.74-1.45],0.8468124387968778
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,24331,53,1.81 [1.25-2.63],0.0016651299812892
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,20857,43,1.15 [0.84-1.58],0.3811472135060352
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,23930,51,1.24 [0.75-2.06],0.3974246366882279
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,20596,45,1.36 [0.95-1.93],0.0895833955914545
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,20503,43,0.65 [0.36-1.20],0.168278575237132
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,24767,53,1.10 [0.69-1.75],0.6960725945575301
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,21225,45,1.15 [0.58-2.29],0.6865543070593937
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,20652,46,1.10 [0.40-2.99],0.8540179840391507
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,24062,52,0.86 [0.56-1.32],0.4863539336347181
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,24498,53,0.96 [0.68-1.36],0.8140888910764988
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",20652,46,0.70 [0.30-1.65],0.4146425914122122
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,20596,45,0.84 [0.42-1.68],0.6247893003483311
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,20857,43,0.96 [0.68-1.38],0.8440444215417098
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,21251,46,1.01 [0.70-1.46],0.9640208039205678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,24483,54,1.62 [1.07-2.47],0.0235495308407341
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,21264,46,0.56 [0.32-0.98],0.041451975592183
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,24498,52,0.69 [0.33-1.45],0.3294461794308742
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,24728,54,1.01 [0.69-1.47],0.964138450351989
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,24498,53,0.91 [0.66-1.25],0.5465810395116872
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,20811,43,0.81 [0.51-1.31],0.3952886613681409
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,21166,45,0.75 [0.58-0.98],0.0323237228157203
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,20503,43,1.42 [1.04-1.95],0.0275779708856934
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,20673,44,0.67 [0.44-1.02],0.0632193864743669
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,24498,53,0.78 [0.59-1.04],0.0864845974238459
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,21142,45,0.84 [0.60-1.17],0.2970078693494582
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,20596,45,1.23 [0.77-1.96],0.3796487252602545
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,20652,46,0.80 [0.50-1.31],0.3794486518693999
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,21225,45,0.76 [0.48-1.20],0.2377341038169343
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,24516,50,0.91 [0.65-1.26],0.5551514457552311
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,24076,51,1.36 [1.01-1.83],0.0406118150614718
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,20596,45,1.10 [0.54-2.25],0.7933419677026039
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,24076,51,1.25 [0.78-2.01],0.3527693007752739
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,20596,45,1.12 [0.68-1.85],0.6489406544273921
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,20603,44,1.13 [0.86-1.48],0.3872724633325756
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,21166,45,1.63 [1.25-2.14],0.0003585592175909
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,20652,46,0.49 [0.22-1.07],0.0740233138790965
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,23899,51,0.79 [0.56-1.10],0.1658361451986597
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,20673,44,0.71 [0.38-1.33],0.2866344308781148
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TTN,Titin,20596,45,1.09 [0.74-1.60],0.6551203989496064
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,21051,45,0.36 [0.21-0.64],0.0003951790269184
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,20603,44,0.61 [0.21-1.73],0.3530771428075182
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,21251,46,0.66 [0.47-0.93],0.0161354199537563
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,20857,43,1.18 [0.86-1.63],0.3044707945301935
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,24350,51,0.74 [0.56-0.98],0.0330062422912878
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,20907,44,0.69 [0.33-1.42],0.310669147133276
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,24556,53,3.41 [1.69-6.84],0.0005816451289972
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,24742,52,0.94 [0.66-1.33],0.713220046139728
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,21201,45,0.53 [0.29-0.99],0.0460794293032647
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,20566,44,0.97 [0.71-1.32],0.8292120556895137
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",24498,52,0.75 [0.44-1.29],0.303547794789947
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,24366,50,1.00 [0.69-1.44],0.9796113820079198
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,24516,50,3.15 [1.32-7.53],0.0099750790167986
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",20652,46,1.09 [0.69-1.73],0.7171063504836015
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,24388,52,1.31 [0.65-2.64],0.4498162411975381
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,21142,45,0.78 [0.28-2.16],0.6312757480255307
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,21259,46,0.90 [0.57-1.43],0.6522454607936248
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,20652,46,0.53 [0.29-1.00],0.049899456764418
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,20596,45,1.01 [0.57-1.78],0.9709420604358048
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,20778,43,0.88 [0.57-1.35],0.5639916008242372
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,21166,45,0.81 [0.66-0.98],0.034108399857437
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,20596,45,0.99 [0.74-1.33],0.9665796696050128
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,20596,45,1.04 [0.46-2.35],0.924777584651953
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,24350,51,3.02 [1.78-5.15],4.631893379503941e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,24715,53,1.08 [0.68-1.70],0.7553540422682496
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,20652,46,1.05 [0.37-2.98],0.930282263009264
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,20503,43,0.49 [0.27-0.91],0.0247298258490042
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,21142,45,0.70 [0.45-1.11],0.1276592525991228
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,21259,46,1.17 [0.88-1.54],0.2796623517467014
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,20603,44,0.93 [0.50-1.74],0.8254060344512839
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,20821,43,0.83 [0.43-1.59],0.565481070042834
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,20778,43,0.78 [0.51-1.20],0.2621895838600719
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,20673,44,1.04 [0.69-1.58],0.8413256989822534
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,24388,52,0.81 [0.62-1.05],0.1162777622305323
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,21142,45,0.82 [0.55-1.22],0.3249947005657402
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,21201,45,0.91 [0.40-2.05],0.8127190967714686
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,20596,45,0.89 [0.62-1.27],0.5174644896934475
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,24076,51,0.90 [0.69-1.17],0.4220973864730079
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,23922,51,1.58 [1.13-2.21],0.0078867214363296
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,24076,51,1.99 [1.64-2.41],1.7345857113190312e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,20652,46,1.00 [0.73-1.37],0.9882191569113832
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,24498,53,0.66 [0.48-0.91],0.010441394584912
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,24093,49,0.84 [0.33-2.13],0.7191723050812964
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,21264,46,0.70 [0.47-1.04],0.078235455448846
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,24388,52,0.57 [0.29-1.11],0.0961305010537297
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,20603,44,0.73 [0.54-0.98],0.035023932047448
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,24534,51,10.89 [6.64-17.84],2.759104849689242e-21
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,24742,52,3.69 [1.74-7.83],0.0006691551975296
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,20503,43,0.91 [0.62-1.32],0.6087061618337166
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,24728,53,0.94 [0.62-1.44],0.787671560965565
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,20652,46,1.65 [0.64-4.22],0.2989825109276893
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,24556,53,0.81 [0.53-1.23],0.3126777149394119
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,24767,53,0.89 [0.47-1.68],0.7120891590594209
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,21225,45,0.66 [0.25-1.70],0.3858981299227724
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,24076,51,1.19 [0.95-1.50],0.130186644376875
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,20668,42,0.66 [0.18-2.40],0.5257020308352673
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,21259,46,0.48 [0.24-0.97],0.0418031446160643
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,24388,52,1.07 [0.74-1.55],0.7351904722629123
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,21264,46,1.22 [0.82-1.81],0.3345633360819723
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,24388,52,1.34 [0.77-2.34],0.2974045508322068
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,20857,43,0.77 [0.48-1.23],0.272190130188066
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,24388,52,0.92 [0.67-1.25],0.5821675825227842
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,21142,45,0.75 [0.55-1.01],0.0598300539893967
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,24388,52,0.76 [0.54-1.06],0.1030399119118716
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,21142,45,1.36 [0.74-2.49],0.3162811334258157
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,20596,45,1.62 [0.82-3.21],0.165207120515115
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,21142,45,1.51 [0.99-2.29],0.0546945334735594
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,24460,52,1.71 [0.95-3.09],0.0756624029555861
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,24481,50,0.85 [0.56-1.28],0.4402964482736523
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,21201,45,1.00 [0.49-2.04],0.9921530931383696
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,23930,51,1.09 [0.67-1.80],0.723237147226421
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,20857,43,1.32 [0.77-2.28],0.3165029832011573
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,24076,51,1.34 [0.96-1.88],0.0804300063765701
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,24742,52,0.65 [0.46-0.93],0.0173901485183868
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,23922,51,3.05 [2.01-4.63],1.811601942309968e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,20778,43,0.63 [0.36-1.10],0.1007483453343234
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,24696,54,2.67 [1.59-4.49],0.0002155244496822
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,20503,43,1.19 [0.91-1.56],0.2062854988707909
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,24262,51,0.91 [0.48-1.74],0.7840165436354107
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,21225,45,1.21 [0.77-1.92],0.4108524593837441
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,24801,53,2.17 [1.61-2.93],3.479170393120428e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",24498,52,1.43 [0.74-2.76],0.2805553043042215
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,24062,52,0.92 [0.63-1.35],0.6787790400169351
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,24076,51,0.84 [0.64-1.11],0.2286216064188301
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,23930,51,1.02 [0.76-1.37],0.8906794679463867
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,21201,45,0.87 [0.59-1.28],0.4729625393780529
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,20652,46,0.96 [0.60-1.55],0.8812992007260955
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,21142,45,1.17 [0.59-2.34],0.6572070966415653
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,20727,45,0.90 [0.49-1.62],0.7160955315712676
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,24686,54,0.96 [0.66-1.41],0.8496166280389291
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,23216,48,2.07 [1.18-3.63],0.0112946426323789
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",24273,51,0.51 [0.28-0.95],0.0330824425651657
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",24527,54,1.49 [0.74-3.02],0.2638564990046323
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,24728,54,2.53 [1.29-4.98],0.0070945494646193
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,24062,52,1.61 [0.78-3.36],0.200656786358042
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,24350,51,0.59 [0.36-0.96],0.0352083550077118
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,24728,54,1.47 [1.08-2.01],0.0149470841326657
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,24673,53,0.79 [0.37-1.68],0.5373205541299422
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,20652,46,0.63 [0.37-1.07],0.0874251313591802
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,24556,53,0.87 [0.69-1.09],0.23096697625732
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,23930,51,0.89 [0.45-1.76],0.735726438743331
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,21201,45,2.84 [1.27-6.36],0.0110417155122835
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",21166,45,0.89 [0.74-1.07],0.2146682040327166
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,24388,52,0.87 [0.70-1.07],0.1914461717207352
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,21142,45,0.46 [0.18-1.17],0.1016003968553149
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,20596,45,0.95 [0.60-1.50],0.821911270605647
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,24062,52,0.74 [0.56-0.99],0.0445656685266275
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,20778,43,0.73 [0.48-1.09],0.1254198837582273
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,20652,46,0.93 [0.33-2.58],0.8839834503686386
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,20652,46,1.02 [0.51-2.02],0.9567964123845576
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,23922,51,0.85 [0.59-1.23],0.3951171392732577
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,24076,51,1.60 [1.04-2.44],0.0317340110831832
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,20596,45,0.75 [0.43-1.33],0.3276780819210186
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,21166,45,0.71 [0.52-0.96],0.0285125674161583
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,21201,45,1.24 [0.66-2.31],0.50545091250517
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,20652,46,1.42 [0.84-2.39],0.1926920686910169
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,20857,43,1.04 [0.66-1.66],0.8569820852532944
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,21142,45,0.93 [0.64-1.35],0.7100891993100189
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,21166,45,0.95 [0.62-1.44],0.7991896340214659
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,21142,45,0.69 [0.39-1.23],0.2040548233576948
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,20668,42,1.02 [0.91-1.14],0.7914530618324049
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,20503,43,0.87 [0.33-2.27],0.7686919798919026
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,20603,44,1.20 [0.96-1.50],0.1045303931799122
